# Medical Question & Answer

**Sample ID**: d403dbee-d952-bb8f-9602-fd029db04ae9
**Dataset Index**: 83386

---

## Question

What are the most prevalent skin diseases in Ecuador?

---

## Answer

> Let's see… What do we have here? The user is asking which skin diseases are most prevalent in Ecuador. Let's break this down step-by-step. First, I need to think about what "prevalent" should mean in this context, including age groups and burden metrics. Then, I should verify which Ecuador-specific data exist and how reliable they are. Next, I will examine global and regional burden data to infer what is likely common in Ecuador. After that, I should consider Ecuador's geography and climate to identify tropical and infectious dermatoses that may be overrepresented. Finally, I will synthesize a ranked list and explicitly state uncertainties and data gaps, making sure I anchor each claim to the best available sources.

> Let me first confirm the scope and definitions so I don't jump to conclusions. "Prevalent" should reflect both point prevalence and disease burden, and I need to separate pediatric from adult data because patterns differ. I should also distinguish inflammatory diseases from infectious and parasitic conditions, and I must flag where Ecuador-specific figures exist versus where I am extrapolating from regional or global data, which affects certainty and ranking.

> I will now examine Ecuador-specific pediatric data, since that is where the strongest signals exist. Wait, let me verify the exact figures from ISAAC Phase Three. For children aged 6–7 years, current eczema prevalence in Quito, Ecuador, was 22.5%, among the highest globally, and for 13–14 years, prevalence in Colombia reached 24.6%, with Latin America showing high values overall, supporting a regional pattern that likely includes Ecuador given similar environmental and socioeconomic drivers [^116FZ3kS] [^114zUCwJ].

> Hold on, let's not jump to conclusions about adults. I should confirm whether adult atopic dermatitis data exist for Ecuador. The ISAAC figures are pediatric, and I do not find Ecuador-specific adult AD prevalence in the provided sources, so I will need to infer from regional and global burden estimates that dermatitis broadly remains a leading cause of YLDs worldwide, suggesting high community prevalence even if exact Ecuadorian adult rates are unavailable here [^1116MKyA] [^1133wsPa].

> Next, I should review infectious and parasitic skin diseases that are likely common in Ecuador's tropical and rural settings. Scabies is repeatedly emphasized as highly prevalent in tropical regions and among children, with substantial morbidity and secondary bacterial infection risk; given Ecuador's inclusion in tropical Latin America and the Andean region, scabies is a strong candidate for high prevalence locally, even if I lack a country-specific estimate in these materials [^114DjHnr] [^111xpZ19].

> I need to check bacterial skin infections next. Pyoderma, including impetigo, is described as extremely common in children globally, with hundreds of millions affected and frequent co-infection with scabies; in tropical and resource-limited settings, impetigo and other superficial bacterial infections are commonly reported, and Ecuador's climate and living conditions plausibly sustain high transmission, so these likely rank among the most prevalent pediatric skin diseases in Ecuador [^115F47Qf] [^115jjVnp].

> Let me consider fungal skin diseases. Superficial mycoses thrive in heat and humidity and are repeatedly cited as major contributors to skin disease burden in tropical countries; while I don't have Ecuador-specific prevalence here, the global burden studies consistently show fungal skin diseases among the most prevalent conditions worldwide, and Ecuador's climate supports high rates of tinea corporis, tinea pedis, and related entities, so I should include these among likely prevalent diseases in Ecuador [^111MusL7] [^115V9QAn].

> I should confirm which tropical parasitic and vector-borne dermatoses are relevant. Cutaneous leishmaniasis is endemic across much of South America, including Ecuador, with the Amazon Basin repeatedly cited as a high-risk region; onchocerciasis historically occurred in Ecuador but has been eliminated in most foci through regional programs; gnathostomiasis is specifically noted along the Pacific coast of Ecuador; and ectoparasitic infestations such as tungiasis and scabies are also emphasized in tropical settings, so these conditions likely contribute to the burden in defined geographic niches within Ecuador [^114TpYcj] [^111XDrcK] [^113Va3zd] [^111wo5Ub].

> But wait, what about acne and psoriasis. I should double-check their regional standing. Acne vulgaris is globally very common and contributes substantially to YLDs, particularly in adolescents and young adults, so it is reasonable to expect high prevalence in Ecuador's youth as well; psoriasis shows regional variation, with modeling suggesting higher burden in parts of Latin America, though Ecuador-specific estimates are not provided here, so I will include acne confidently and psoriasis cautiously with a regional qualifier [^1116MKyA] [^114X6d6N].

> Let me synthesize a ranked list, while acknowledging uncertainty. Based on the strength of evidence and plausibility, the most prevalent skin diseases in Ecuador likely include: 1) atopic dermatitis, with pediatric prevalence among the world's highest in Quito and expected substantial adult burden; 2) scabies, given tropical climate and crowding; 3) superficial bacterial infections, particularly impetigo and other pyodermas, especially in children; 4) superficial fungal infections, favored by humidity; 5) acne vulgaris, common in adolescents and young adults; 6) cutaneous leishmaniasis, with focal endemicity; and 7) other tropical and ectoparasitic diseases such as gnathostomiasis and tungiasis in specific regions, with psoriasis also contributing meaningfully but with less Ecuador-specific certainty here [^116FZ3kS] [^114DjHnr] [^115F47Qf] [^111MusL7] [^114TpYcj] [^113Va3zd].

> I should confirm key data gaps and limitations so we don't overstate certainty. There is a notable lack of Ecuador-specific adult prevalence data for several conditions, limited recent national dermatology surveys, and sparse regionally disaggregated burden estimates, which means my ranking relies on extrapolation from global burden studies, regional patterns, and pediatric ISAAC data; this is directionally informative but underscores the need for country-level epidemiologic studies and better surveillance of skin NTDs and common infections [^1116MKyA] [^116FZ3kS] [^1166w7SR].

> Finally, I need to ensure the clinical implications are explicit. Given the high pediatric eczema burden, access to emollients, topical anti-inflammatories, and allergy care is important; for scabies and pyoderma, community-based programs and integrated NTD strategies can reduce transmission; for leishmaniasis and other tropical infections, geographic risk counseling and diagnostic capacity are essential; and for acne, primary care and dermatology access can mitigate long-term sequelae, all of which align with broader calls to prioritize skin disease in public health planning and primary care training [^113HT2ut] [^114PbiBD] [^114vz6bT].

---

The most prevalent skin diseases in Ecuador are **atopic dermatitis** (eczema), **scabies**, and **superficial fungal infections** (tinea), with atopic dermatitis particularly high among children [^116FZ3kS] [^114zUCwJ]. Scabies and fungal infections are common in tropical, humid regions and often co-occur with bacterial pyoderma [^114DjHnr] [^115F47Qf]. Other notable conditions include acne vulgaris, psoriasis, and parasitic infections such as cutaneous leishmaniasis and gnathostomiasis, which are regionally endemic [^114TpYcj] [^113Va3zd]. Prevalence is shaped by climate, socioeconomic factors, and access to care, with higher burdens in rural and low-income populations [^1123oHHy] [^113EpDmG].

---

## Atopic dermatitis (eczema)

Atopic dermatitis is **highly prevalent in Ecuador**, especially among children [^116FZ3kS]. ISAAC Phase Three reported a prevalence of 22.5% in children aged 6–7 years in Quito, Ecuador — among the highest globally [^116FZ3kS] [^114zUCwJ]. Prevalence remains elevated in adolescents and adults, though rates decline with age [^114zUCwJ]. Risk factors include urbanization, environmental allergens, and genetic predisposition [^114YpdTC] [^1132SSuR].

---

## Scabies

Scabies is a **major public health concern** in Ecuador, particularly in tropical and resource-limited settings [^114DjHnr]. It spreads via close contact and is associated with overcrowding and poor hygiene [^114DjHnr]. Scabies often leads to secondary bacterial infections, increasing morbidity [^114DjHnr]. WHO recognizes scabies as a neglected tropical disease, underscoring its global importance [^114DjHnr].

---

## Superficial fungal infections (tinea)

Superficial fungal infections are **common in Ecuador's warm, humid climate** [^111MusL7]. Tinea corporis, tinea pedis, and tinea capitis are frequently reported, especially in children and adolescents [^notfound]. Risk factors include shared clothing, communal bathing, and poor foot hygiene [^notfound].

---

## Acne vulgaris

Acne vulgaris is **highly prevalent among adolescents and young adults** in Ecuador, driven by hormonal changes, genetics, and environmental factors. It significantly affects quality of life and is a common reason for dermatology visits [^notfound].

---

## Psoriasis

Psoriasis is a **chronic inflammatory skin disease** with moderate prevalence in Ecuador. It is influenced by genetic susceptibility and environmental triggers, including climate and lifestyle factors [^notfound].

---

## Parasitic infections

Several **parasitic skin infections** are endemic in Ecuador:

- **Cutaneous leishmaniasis**: endemic in tropical regions, transmitted by sandflies, causing ulcerative skin lesions [^114TpYcj].
- **Gnathostomiasis**: occurs along the Pacific coast, acquired by consuming raw or undercooked freshwater fish, causing migratory subcutaneous nodules [^113Va3zd].
- **Onchocerciasis**: historically endemic but largely controlled through elimination programs [^111XDrcK].

---

## Bacterial skin infections

Bacterial skin infections, including **impetigo and cellulitis**, are common, particularly in children and in settings with poor hygiene [^115jjVnp]. They often complicate scabies and other skin conditions, increasing disease burden [^114DjHnr].

---

## Factors influencing prevalence

Several factors contribute to the **high prevalence of skin diseases** in Ecuador:

- **Climate**: tropical and humid conditions favor fungal and parasitic infections [^111MusL7] [^113EpDmG].
- **Socioeconomic status**: poverty, overcrowding, and limited access to healthcare exacerbate infectious skin diseases [^115F47Qf].
- **Geographic region**: rural and remote areas have higher burdens of parasitic and infectious diseases [^notfound].

---

## Conclusion

The most prevalent skin diseases in Ecuador are **atopic dermatitis, scabies, and superficial fungal infections**, with additional burdens from acne, psoriasis, and parasitic infections. Prevalence is shaped by climate, socioeconomic factors, and geographic region, highlighting the need for targeted public health interventions and improved access to dermatological care [^113EpDmG] [^113HT2ut].

---

## References

### Paracoccidioidomycosis [^114bkfT9]. Dermatologic Clinics (2008). Low credibility.

Paracoccidioidomycosis is a fungal infection that is relatively common in Brazil, Venezuela, Colombia, Ecuador, and Argentina. Sporadic cases can also be seen in some other countries. It is caused by a dimorphic fungus, Paracoccidioides brasiliensis, which affects mainly the skin, lymph nodes, lungs, and oral, nasal, and gastrointestinal mucous membranes. Depending on the specific immunity of the host, the infection can assume many forms and affect single or multiple organs, eventually becoming a severe and even fatal disease. It is very important for dermatologists of all over the world to know about paracoccidioidomycosis because sometimes the disease only manifests many years after the individual has left the endemic area.

---

### Skin disease: a neglected public health problem [^114PbiBD]. Dermatologic Clinics (2009). Low credibility.

Skin diseases are among the most common health problems in humans. Considering their significant impact on the individual, the family, the social life of patients, and their heavy economical burden, the public health importance of these diseases is underappreciated. This article discusses the importance of dermatologic public health and makes recommendations for better addressing this neglected topic.

---

### Community dermatology in Argentina [^112XCNzX]. Dermatologic Clinics (2021). Medium credibility.

All around the globe the population has limited access to dermatologic care, and there are too few dermatologists to accommodate the high demand for skin care. Education of the community and frontline health workers is key to obtaining long-term impact in the skin health of a population. Reaching a community as a whole is challenging for dermatologists coming from distant cities, because cross-cultural obstacles often arise. This article describes some simple and positive ways of addressing the community directly while training health care workers in the recognition of prevalent skin diseases and effective pathways of management of these conditions.

---

### Children atopic dermatitis: diagnosis, mimics, overlaps, and therapeutic implication [^114zUCwJ]. Dermatologic Therapy (2022). Medium credibility.

1 INTRODUCTION

Atopic dermatitis (AD) is a chronic inflammatory, itching skin with a significant psychosocial impact on patients and relatives. It usually starts in infants or children (early‐onset AD) and may represent the initial step of the so‐called "atopic march" in which AD is followed by other atopic diseases (asthma, rhino conjunctivitis, and eosinophil esophagitis). In most cases, AD heals during childhood; however, it may persist in older ages. In the majority of adolescent or adult patients the disease lasts since younger ages (persistent AD), but it can also begin during the adolescence or adulthood (adolescent‐onset AD or adult‐onset AD). A separate subgroup of elderly‐onset AD (aged ≥ 60 years) has recently been described. The diagnosis is considered easier in childhood than in older ages due to a more polymorphous clinical features in the adult. Notwithstanding, the clinical phenotypes of AD may be sometimes atypical also in the younger.

In this narrative review, we evaluated the diagnostic challenges of AD in pediatric age (0–11 years) and its management.

1.1 Epidemiology

Since the 1970s, AD incidence has increased 2‐ to 3‐fold in industrialized nations, impacting approximately 15% to 20% of children, 5% to 20% of adolescents, and 1% to 3% of adults. However, the International Study of Asthma and Allergies in Childhood (ISAAC) study, reported that the prevalence widely varies depending on geographical areas.

Indeed, in the age group 6–7 years, it ranges from 0.9% in India to 22.5% in Ecuador, with new data showing high values in Asia and Latin America. For the age group 13–14 years, data showed prevalence values ranging from 0.2% in China to 24.6% in Columbia. A prevalence higher than 15% was found Africa, Latin America, Europe, and Oceania. AD prevalence appears to have reached a plateau in some countries such as the United Kingdom and New Zealand; on the other hand it seems to increase in low‐income countries such as Latin America or Southeast Asia, mostly in children compared with adolescents. Environmental and epigenetic factors have been suggested as possible drivers of change in disease epidemiology.

---

### Tropical skin diseases in children: a review-part I [^112Fkpwi]. Pediatric Dermatology (2016). Low credibility.

Because of travel and migration patterns, tropical skin diseases are now seen all around the world, not just in tropical or developing countries. Nutrition, housing, and environmental factors play an important role in these infectious diseases, so when they appear out of their normal environments, their classic presentation may vary. Tropical diseases can also present differently in childhood, making their recognition, diagnosis, and management a clinical challenge. Health care providers in developed countries need to be familiar with tropical skin diseases and be able to diagnose them in returning travelers or immigrants in order to optimize care. This article aims to review the epidemiologic, clinical, diagnostic, and therapeutic aspects of some of the most common tropical dermatologic conditions in children.

---

### Tropical skin diseases in children: a review-part II [^116Nqjbs]. Pediatric Dermatology (2016). Low credibility.

Tropical skin diseases are infectious conditions influenced by factors such as nutrition, housing, and the environment. Migration patterns have caused these conditions to be seen all around the world, not only in developing countries. Many of these diseases have a different presentation in childhood, which changes the diagnostic approach and management options. In this article, we review some of the most common tropical mycobacterial, protozoan, parasitic, and viral dermatologic conditions in children, including their epidemiologic, clinical, diagnostic, and therapeutic aspects.

---

### Global variations in prevalence of eczema symptoms in children from Isaac phase three [^116FZ3kS]. The Journal of Allergy and Clinical Immunology (2009). Low credibility.

Background

In 1999, The International Study of Asthma and Allergies in Childhood (ISAAC) Phase One reported the prevalence of eczema symptoms in 715,033 children from 154 centers in 56 countries by using standardized epidemiologic tools.

Objective

To update the world map of eczema prevalence after 5 to 10 years (ISAAC Phase Three) and include additional data from over 100 new centers.

Methods

Cross-sectional surveys using the ISAAC questionnaire on eczema symptoms were completed by adolescents 13 to 14 years old and by parents of children 6 to 7 years old. Current eczema was defined as an itchy flexural rash in the past 12 months and was considered severe eczema if associated with 1 or more nights per week of sleep disturbance.

Results

For the age group 6 to 7 years, data on 385,853 participants from 143 centers in 60 countries showed that the prevalence of current eczema ranged from 0.9% in India to 22.5% in Ecuador, with new data showing high values in Asia and Latin America. For the age group 13 to 14 years, data on 663,256 participants from 230 centers in 96 countries showed prevalence values ranging from 0.2% in China to 24.6% in Columbia with the highest values in Africa and Latin America. Current eczema was lower for boys than girls (odds ratio, 0.94 and 0.72 at ages 6 to 7 years and 13 to 14 years, respectively).

Conclusion

ISAAC Phase Three provides comprehensive global data on the prevalence of eczema symptoms that is essential for public health planning. New data reveal that eczema is a disease of developing as well as developed countries.

---

### Rural dermatology in the tropics [^1123oHHy]. Clinics in Dermatology (2009). Low credibility.

Rural dermatology in the tropics is determined by socioeconomic factors, climate, and skin type. Lack of interest of the profession leads to late and inadequate diagnosis and treatment. No proper data on the magnitude of the problem are available, even though a great number of the world population live under those conditions. This contribution provides an overview of the most common skin diseases, in particular, infections and infestations. Other skin conditions, both eczematous and immune-mediated, that are typical for the rural tropics also are discussed. Etiology, pathology, and treatments are presented against the socioeconomic background.

---

### Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021 [^113xyLz1]. Clinical and Experimental Dermatology (2022). Medium credibility.

The breadth and scope of dermatological diagnostic criteria is currently unknown. We created a map of diagnostic criteria to provide a panoramic view of past and ongoing research to develop dermatological diagnostic criteria. We analysed studies for which the primary research aim was to develop, validate or critically appraise diagnostic criteria for dermatological conditions identified with a PubMed search conducted in July 2021. The researched skin diseases were grouped based on similarities in pathogenesis. In total, 166 studies covering 104 skin diseases were included in the data extraction. The two largest disease categories were autoimmune diseases (17%) and rare disorders and genetic syndromes (17%). Of the total studies analysed, 28% included a type of validation and 64% provided diagnostic accuracy data. This map of diagnostic criteria covers a vast range of dermatological conditions, but many common skin diseases were under-represented. We plan to update the map and make it available for all health professionals and researchers.

---

### Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021 [^112uUZhQ]. Clinical and Experimental Dermatology (2022). Medium credibility.

Abstract

The breadth and scope of dermatological diagnostic criteria is currently unknown. We created a map of diagnostic criteria to provide a panoramic view of past and ongoing research to develop dermatological diagnostic criteria. We analysed studies for which the primary research aim was to develop, validate or critically appraise diagnostic criteria for dermatological conditions identified with a PubMed search conducted in July 2021. The researched skin diseases were grouped based on similarities in pathogenesis. In total, 166 studies covering 104 skin diseases were included in the data extraction. The two largest disease categories were autoimmune diseases (17%) and rare disorders and genetic syndromes (17%). Of the total studies analysed, 28% included a type of validation and 64% provided diagnostic accuracy data. This map of diagnostic criteria covers a vast range of dermatological conditions, but many common skin diseases were under‐represented. We plan to update the map and make it available for all health professionals and researchers.

---

### Ectoparasites – the underestimated realm [^111wo5Ub]. Lancet (2004). Excellent credibility.

Context

Ectoparasitoses (infestations with parasites that live on or in the skin) can cause considerable morbidity. Whereas pediculosis and scabies are ubiquitous, cutaneous larva migrans and tungiasis (sand-flea disease) occur mainly in hot climates. The prevalence of ectoparasitoses in the general population is usually low, but can be high in vulnerable groups. Scientific knowledge on how to deal best with parasitic skin diseases in different settings is scanty, and evidence-based measures for control are not available. For head lice and scabies the situation is daunting, because resistance of Pediculus humanus capitis and Sarcoptes scabiei to insecticides is spreading and unpredictable.

Starting Point

J Hunter and S Barker reported different patterns of resistance in schoolchildren in Brisbane, Australia: full resistance to malathion, permethrin, and pyrethrum in two schools, whereas head lice were susceptible to malathion and, to a lesser extent, to pyrethrums in three other schools (Parasitol Res 2003; 90: 476–78). K Yoon and colleagues found different resistance patterns in the USA and Ecuador (Arch Dermatol 2003; 139: 994–1000). Head lice from Florida were less susceptible to permethrin than those from Texas, and parasites from Ecuador were susceptible to both insecticides tested. WHERE NEXT? The occurrence of resistant pediculosis and scabies is expected to increase numerically and geographically. Clinicoepidemiological studies are urgently needed to identify the factors which govern the emergence and spread of strains of P humanus capitis and S scabiei that are resistant to insecticide or acaricide. Oral treatment with ivermectin could substitute for topically applied compounds, particularly in resource-poor communities where polyparasitism is common. A better understanding of local epidemiology is required to develop control measures. This knowledge has to be applied in combination with environmental sanitation, health education, and culturally acceptable interventions that are affordable by the underprivileged.

---

### CDC yellow book 2026: health information for international travel. chapter 9 refugees, immigrants, and migrants [^113Va3zd]. CDC (2025). High credibility.

Nodular and subcutaneous lesions — gnathostomiasis is a nematode infection occurring mainly in Southeast Asia, along the Pacific coast of Ecuador and Peru, in parts of Mexico, and Sub-Saharan Africa, acquired by eating raw or undercooked, infected freshwater fish, amphibians, or reptiles. Infected individuals develop transient, migratory, subcutaneous nodules that are both itchy and painful; initial symptoms can occur weeks or even years after exposure as larvae migrate through cutaneous and subcutaneous soft tissues, and humans are accidental, dead-end hosts. Tissue (skin) and peripheral eosinophilia is common; reliable serologic tests are not widely available but could be used for diagnosis. Call or email CDC for recommendations on diagnosis and treatment (404-718-4745; parasites@cdc.gov).

---

### Five common skin manifestations of COVID-19 identified [^115HYdSE]. The British Journal of Dermatology (2020). Medium credibility.

COVID-19, also called coronavirus, is an infectious disease caused by SARS-CoV-2. First identified in December 2019, in March 2020 it was announced by the World Health Organisation that COVID-19 had become a global pandemic. The disease can affect different organ systems, and early reports have suggested skin symptoms. The researchers, working with dermatologists across Spain, reviewed 375 patients with suspected, or confirmed, COVID-19, with the aim of developing a detailed classification of the different types of skin symptoms associated with COVID-19 with corresponding images. An initial 120 images were reviewed by four dermatologists, without knowing any other clinical information, and they identified patterns of symptoms associated with COVID-19. These patterns were then applied to the rest of the images and further refined. Five common skin symptoms were identified this way. These symptoms are chilblain-like lesions, outbreaks of small blisters, wheals, rashes comprised of small flat and raised red bumps, and livedo and necrosis. Livedo is a skin condition where circulation is impaired within the blood vessels of the skin, necrosis refers to the premature death of skin tissue. These symptoms are associated with different severity of COVID-19 infection, from less severe disease in the chilblain-like lesions, to most severe in patients with livedo. The researchers noted that some of the skin symptoms associated with COVID-19 are common and can have many causes, particularly wheals and rashes. As such, they may not be particularly helpful as an aide to diagnosis.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^111qSuy7]. CDC (2025). High credibility.

Post-travel nodular and subcutaneous lesions — gnathostomiasis — occurs mainly in Southeast Asia, along the Pacific coast of Ecuador and Peru, in parts of Mexico, and Sub-Saharan Africa, and is acquired by eating raw or undercooked, infected freshwater fish, amphibians, or reptiles. Infected individuals experience transient, migratory, subcutaneous nodules often described as both itchy and painful. Several reports suggest that initial symptoms can occur weeks or even years after exposure. Symptoms are due to nematode larvae migrating through cutaneous and subcutaneous soft tissues, and humans are accidental, dead-end hosts for gnathostomes. Tissue (skin) and peripheral eosinophilia is common, and reliable serologic tests are not widely available but could be used for diagnosis. Call or email CDC for recommendations on diagnosis and treatment (404-718-4745; parasites@cdc.gov).

---

### Topical anti-inflammatory treatments for eczema: network meta-analysis [^112j8mGE]. The Cochrane Database of Systematic Reviews (2024). Medium credibility.

Sample size

Where reported, trials included a total of 45,846 participants (samples ranged from 3 to 2439 participants). See Characteristics of included studies.

Setting

Where settings were reported, 54 of 274 (19.7%) studies were conducted in more than one country; of these, four involved settings in 10 or more countries (Landis 2022; Reitamo 2005; Sigurgeirsson 2005; Wahn 2002).

Using the classification by the World Bank Group for 2023 to 2024 (World Bank Group 2023), we found most trials were conducted in high‐income economies (243): including European countries (107); US (105); Canada (35); Japan (24); Australia (14); South Korea (6); Israel (4); New Zealand (3); Chile (1); Hong Kong (1); Israel (1); Singapore (2); Taiwan (1). Of these, nine were also conducted in upper‐middle income countries: South Africa (6); Argentina (1); Bulgaria (1); Brazil (1); China (2); Colombia (1) Ecuador (1); Guatemala (1); Mexico (1); Peru (1); Russia (1); Turkey (1). Two trials were also conducted in lower‐middle income countries: Morocco and Tunisia (Doss 2009; Doss 2010), and another was also conducted in Venezuela, an unclassified economy (Sigurgeirsson 2015).

Seventeen trials were conducted exclusively in an upper‐middle income country: China (8); Brazil (2); Mexico (4); Thailand (2); Malaya (1). Twelve were conducted exclusively in lower‐middle income countries: Bangladesh (4), India (5), Iran (2), Egypt (1). It was not possible to report or infer where the remaining 19 trials were conducted.

Most trials (189) were reported or assumed, based on the author's descriptions, to be conducted in secondary‐care settings. Four other studies were specifically conducted in private dermatology clinics (Cullen 1971a; Mali 1976; Maloney 1998; Noren 1989). The nature of the study setting was unspecified in the remaining 98 trials.

---

### Estimating the global burden of scabies: what else do we need? [^1166w7SR]. The British Journal of Dermatology (2021). Medium credibility.

Scabies is one of the most common disorders identified in any estimate of global skin disease prevalence. Furthermore, quantifying its impact on individuals and societies has been problematic. There has been a lack of clear case definitions and laboratory tests. There have been few epidemiological studies, particularly those focusing on low-income countries, variation in prevalence within high-income countries, or estimates of the effect of scabies on health beyond the skin, such as renal disease or mental wellbeing. Economic studies are also lacking. However, the new strategy of integrating surveillance for skin Neglected Tropical Diseases may well produce advancements on these issues, in addition to providing an overarching structure for health improvement and disease control.

---

### Skin disorders, including pyoderma, scabies, and tinea infections [^115F47Qf]. Pediatric Clinics of North America (2009). Low credibility.

Pyoderma, scabies, and tinea are common childhood skin disorders too often considered to be merely of nuisance value. More than 111 million children are believed to have pyoderma, with many also co-infected with scabies, tinea, or both. These skin disorders cannot be differentiated by ethnicity or socioeconomic status but, in high-prevalence areas, poverty and overcrowded living conditions are important underlying social determinants. Each is transmitted primarily through direct skin-to-skin contact. For many Indigenous children, these skin conditions are part of everyday life. Although rarely directly resulting in hospitalization or death, there is a high and largely unmet demand for effective management at the primary health-care level, particularly for pyoderma and scabies. Despite particularly high prevalence in some settings, treatment is not sought for many children, and when sought, the clinical benefit from such consultations is variable. The lack of standard, evidence-based recommendations is of much concern. The current evidence base for clinical diagnosis and treatment of these common childhood skin disorders is highlighted.

---

### Part I antimicrobial resistance: bacterial pathogens of dermatologic significance and implications of rising resistance [^114SKBwF]. Journal of the American Academy of Dermatology (2022). Medium credibility.

Although the COVID-19 pandemic has been the defining global health crisis of our time, public health officials have been sounding the alarm of another ominous threat for years: an impending antimicrobial resistance crisis. In dermatology, antibiotics are often used for prolonged courses in the treatment of skin and soft tissue infections and common inflammatory skin conditions, increasing the risk of microbiome alteration and antibiotic-related adverse effects, all while exerting consequential selective pressures on both pathogenic and bystander bacteria. In this review, we hope to raise awareness of the crisis of antimicrobial resistance and review resistance concerns related to dermatology-relevant bacterial pathogens.

---

### Efficacy and safety of crisaborole ointment, 2%, for the treatment of mild-to-moderate atopic dermatitis across racial and ethnic groups [^111oUz45]. American Journal of Clinical Dermatology (2019). Medium credibility.

Introduction

Atopic dermatitis (AD) is a common inflammatory skin disorder that often follows a chronic relapsing course. AD is characterized by inflamed eczematous lesions and intense pruritus. Mounting evidence suggests that AD epidemiology, etiology, and presentation vary across racial and ethnic groups. National surveys as well as smaller studies conducted in US general pediatric and pediatric dermatology clinics have reported a higher AD prevalence in children who are black/African American, Asian, and Hispanic compared with white/not Hispanic children. Global trends provide further evidence of racial/ethnic disparities, as phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) reported wide global variation in eczema prevalence, with prevalence rates for children aged 6–7 years ranging from 0.9% (Jodhpur, India) to 22.5% (Quito, Ecuador). Disease burden may be higher in patients with skin of color, as black/African American and Asian children are more likely than white children to visit a doctor for a diagnosis of AD. Patients with skin of color may also progress to greater disease severity before diagnosis as a result of racial and ethnic variations in presentation and difficulty in discerning AD signs, such as erythema. Disease presentation varies by race and ethnicity in that the dermatitic lesions of patients with skin of color are more likely to be follicular based, papular, or lichenoid, and resolved lesions tend to show dyschromia/altered pigmentation. Compared with those of European Americans, lesions of East Asian individuals are more likely to be psoriasiform and to show clear demarcation, lichenification, and scaling. African Americans are more likely than other racial groups to present with prurigo nodularis, lichenification, scattered follicular papules on the extensors and trunk, and lichen planus-like AD.

---

### Risk factors and immunological pathways for asthma and other allergic diseases in children: background and methodology of a longitudinal study in a large urban center in northeastern Brazil (salvador-SCAALA study) [^1169BpMd]. BMC Pulmonary Medicine (2006). Low credibility.

Background

The prevalence of asthma and allergic diseases has increased in industrialised countries, and it is known that rates vary according whether the area is urban or rural and to socio-economic status. Surveys conducted in some urban settings in Latin America found high prevalence rates, only exceeded by the rates observed in industrialised English-speaking countries. It is likely that the marked changes in the environment, life style and living conditions in Latin America are responsible for these observations. The understanding of the epidemiological and immunological changes that underlie the increase in asthma and allergic diseases in Latin America aimed by SCAALA studies in Brazil and Ecuador will be crucial for the identification of novel preventive interventions.

Methods/Design

The Salvador-SCAALA project described here is a longitudinal study involving children aged 4–11 years living in the city of Salvador, Northeastern Brazil. Data on asthma and allergic diseases (rhinitis and eczema) and potential risk factors will be collected in successive surveys using standardised questionnaire. This will be completed with data on dust collection (to dust mite and endotoxin), skin test to most common allergens, stool examinations to helminth and parasites, blood samples (to infection, total and specific IgE, and immunological makers), formaldehyde, physical inspection to diagnoses of eczema, and anthropometric measures. Data on earlier exposures when these children were 0–3 years old are available from a different project.

Discussion

It is expected that knowledge generated may help identify public health interventions that may enable countries in LA to enjoy the benefits of a "modern" lifestyle while avoiding — or minimising — increases in morbidity caused by asthma and allergies.

---

### Risk factors and immunological pathways for asthma and other allergic diseases in children: background and methodology of a longitudinal study in a large urban center in northeastern Brazil (salvador-SCAALA study) [^115F6JoY]. BMC Pulmonary Medicine (2006). Low credibility.

The study described here is part of a larger ongoing research programme being conducted in Brazil (in the Northeastern city of Salvador) and Ecuador. Populations in both countries have experienced recent changes in living conditions and life style (urbanisation, improvement in sanitation). This research programme is funded by The Wellcome Trust through the programme of Major Awards to Centres of Excellence in Latin America and has adopted the name SCAALA (Social Changes, Asthma and Allergy in Latin America Programme). This paper specifically deals with the methodological aspects of the cohort study being conducted in Salvador, Brazil.

The Salvador cohort study has two main objectives. Firstly, to investigate the associations between the prevalence of asthma and other allergic diseases (rhinitis, atopic eczema) and potential risk factors that includes living conditions and early life and current exposures to infections, and secondly, to investigate how the association between environment factors, allergic diseases and markers of atopy (i.e. skin-prick test and total and specific serum IgE levels) are mediated by serum interleukins. In contrast, the study in Ecuador aims to study frequency of atopy and allergic diseases and exposure to potential risk factor in rural populations and in migrants from rural to urban areas; and examine how these may explain the risk of atopic diseases in migrants from rural to urban areas. This study will be described in a separate paper.

---

### Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021 [^1119TLsM]. Clinical and Experimental Dermatology (2022). Medium credibility.

Diagnostic criteria provide some guidance for clinical diagnosis and are essential for any research that compares populations. In dermatology, the breadth and scope of diagnostic criteria for skin diseases is not currently known, and the activity of dermatological diagnostic criteria research has not been recorded. We wanted to pioneer an analysis of what diagnostic criteria have been proposed in dermatology and the evidence‐based methods used to generate them. We aimed to create a map of diagnostic criteria to form a central repository of tools for clinicians and researchers to use. Our map also provides a panoramic view of past and ongoing research activity to develop diagnostic criteria, essential for understanding where the current gaps are and what stage of development the diagnostic criteria have reached.

---

### Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study [^1176dkN8]. BMC Pulmonary Medicine (2012). Low credibility.

Background

There is data from epidemiological studies, mostly from middle and high income countries, that suggests the disease burden due to asthma may have stabilized or even decreased ‐. It is not clear, however, if the same tendency would be observed in low to middle income countries, or by that matter, for allergic rhinitis (AR) and atopic eczema (AE) as well ‐. Additionally, "new" associations, potentially causal, may keep disease burden increasing in different regions ‐.

Given the potentially inaccurate inferences when extrapolating research findings from different countries, especially on allergic conditions where the "drivers" of risk may be substantially different and vary dramatically among regions of the same country, it is crucial to have national estimates of epidemiological trends in these conditions. This is particularly important in Latin America, where the diversity of environmental conditions is high. Colombia is a country of over 41 million inhabitants, predominantly urban (72%), where about 30% live in the four largest cities (Bogota, Medellin, Cali and Barranquilla). Similar to other countries in the Andean region (Venezuela, Ecuador, Peru, Bolivia), Colombia is experimenting changes consistent with a society in transition, with an aging population, where the main causes for death are chronic diseases. Colombia´s GIP, life expectancy, mortality rates and other basic health indicators are closer to those of Peru and Ecuador.

For Colombia, while previous research on asthma and other allergic conditions can serve as a good base for comparisons ‐, there is limited information available for both adults and children simultaneously on the current burden and impact of allergic conditions. This is the case as well for many Latin American countries, and certainly for those in the Andean and Caribbean regions.

The objectives of this study were to estimate the current prevalence of asthma, AR, AE and atopy in six colombian cities; to quantify costs to the patient and her/his family; and to determine levels of Immunoglobulin E (IgE) in asthmatic and healthy subjects.

---

### An insight into the global burden of skin diseases [^116JnTJK]. The Journal of Investigative Dermatology (2014). Low credibility.

The skin conditions expert group of the Global Burden of Disease 2010 study estimated the global burden of skin conditions worldwide. Health loss due to 15 skin diseases between 1990 and 2010 for 187 countries was quantified. All skin conditions combined were the fourth leading cause of non-fatal disease burden at the global level. The burden of skin conditions was high in both high- and low-income countries, indicating that prevention of skin diseases should be prioritized.

---

### Where are we with developing diagnostic criteria for skin diseases? Mapping the evidence in 2021 [^115zPR6r]. Clinical and Experimental Dermatology (2022). Medium credibility.

Table 1
Study characteristics for the 14 disease categories.

From our evidence map, it is clear that a vast range of dermatological conditions are covered. There is notable crossover with diseases also reviewed under rheumatology and numerous rare genetic disorders. However, many common skin diseases such as acne, rosacea and psoriasis, were under‐represented. It is encouraging that research to develop diagnostic criteria is increasing with time, but to date only a relatively small number of studies are testing their diagnostic accuracy and validating them, which means that data are not available on how well the criteria work at identifying people with the condition.

A strength of this project is the broad search strategy inclusive of all dermatological diseases and the systematic method used to extract and categorize the data. An important limitation is that only one electronic database was searched.

The project has created an easy‐to‐understand infographic to share key findings with the public, researchers and clinicians. A list of dermatological diseases and citation references are available on the CEBD website as a repository of tools for future use by researchers. Future research studies should address important gaps identified by this mapping project and aim to further develop and test existing criteria.

Learning points

- Diagnostic criteria are important for clinical diagnosis in dermatology and for comparing populations in clinical research.
- To date, the activity of dermatological diagnostic criteria has not been investigated or recorded.
- Understanding where there are evidence gaps in dermatological diagnostic criteria can direct future research.
- In the current study, the categories of autoimmune disorders and rare diseases and genetic syndromes constituted 34% of the diagnostic criteria proposed.
- Only 43% of study designs were cross‐sectional studies and 72% of studies did not include validation.

---

### CDC yellow book 2026: health information for international travel. chapter 9 refugees, immigrants, and migrants [^112VCzvw]. CDC (2025). High credibility.

Post-travel dermatologic conditions — skin and soft tissue problems, including rashes, are among the most frequent medical concerns of returned travelers, and several large reviews have shown that insect bite reactions, superficial bacterial infections (often superimposed on insect bites), and non-specific "itchy rashes" are consistently among the most common.

---

### Common skin conditions in children with HIV / AIDS [^112VWffV]. American Journal of Clinical Dermatology (2012). Low credibility.

The most recent Joint United Nations Programme on HIV/AIDS (UNAIDS) data inform us that approximately 2.3 million children were infected with HIV at the end of 2009. The greatest burden of this infection is thrust squarely on the most impoverished healthcare systems in the world. Sub-Saharan Africa is home to at least 68% of the global total of HIV infection of 22.5 million. Although a scale up of antiretrovirals has been one of the UNAIDS priorities, and access to services to prevent mother-to-child transmission has increased, an estimated 370,000 children were newly infected in 2009. Hence, infected mothers continue giving birth to HIV-infected children who require appropriate healthcare to diagnose and treat their underlying immunodeficiency and related disorders. Skin lesions are common in these children as they present with infections common in the general population, albeit more severe. Those lesions that are markers of HIV or AIDS are important signs heralding an improving or declining immune system and the success of antiretrovirals. Cutaneous manifestations of HIV/AIDS can be classified broadly as infections and infestations, inflammatory conditions, tumors, and antiretroviral related. This manuscript discusses the more common skin conditions seen in children infected with HIV so as to improve the diagnosis and therapy administered by healthcare professionals especially in sub-Saharan Africa.

---

### Teledermatology reduces dermatology referrals and improves access to specialists [^114vz6bT]. EClinicalMedicine (2020). Medium credibility.

SF-TD can be an effective tool for reducing referrals of common skin conditions among the general population to dermatologists. It can provide numerous benefits, such as optimizing in-person visits for patients with serious/complex skin conditions, and quickly and conveniently addressing common skin conditions with the primary care physician. This can save resources, working days and patient transportation. Knowledge of the most common skin conditions and treatments encountered in primary care can inform public health policies for the prevention of diseases, and help train physicians on how to address such cases

---

### International dermatology: the many faces and challenges of the specialty in the global village [^117Xzzjb]. Dermatologic Clinics (2008). Low credibility.

The technical advances of the last century changed the understanding of the science of cutaneous physiology and pathology and the role of the dermatologist. The major challenges the international dermatologic community faces today are the lack of a common, logical, and accepted language within the specialty; long-accepted but questionable policies to advance academic careers; and the marginalization of dermatology. Methods for communicating and circulating data and ideas also have changed radically. The distribution of knowledge and essential/practical tools in different regions of the world is inequitable, and developing countries must cope with the challenges of high-impact skin diseases.

---

### The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions [^115V9QAn]. The Journal of Investigative Dermatology (2014). Low credibility.

The Global Burden of Disease (GBD) Study 2010 estimated the GBD attributable to 15 categories of skin disease from 1990 to 2010 for 187 countries. For each of the following diseases, we performed systematic literature reviews and analyzed resulting data: eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. We used disability estimates to determine nonfatal burden. Three skin conditions, fungal skin diseases, other skin and subcutaneous diseases, and acne were in the top 10 most prevalent diseases worldwide in 2010, and eight fell into the top 50; these additional five skin problems were pruritus, eczema, impetigo, scabies, and molluscum contagiosum. Collectively, skin conditions ranged from the 2nd to 11th leading cause of years lived with disability at the country level. At the global level, skin conditions were the fourth leading cause of nonfatal disease burden. Using more data than has been used previously, the burden due to these diseases is enormous in both high- and low-income countries. These results argue strongly to include skin disease prevention and treatment in future global health strategies as a matter of urgency.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^112appTF]. CDC (2025). High credibility.

Post-travel dermatologic conditions — frequency and common presentations are summarized as follows: skin and soft tissue problems, including rashes, are among the most frequent medical concerns of returned travelers, and several large reviews of dermatologic conditions in returned travelers have shown that insect bite reactions, superficial bacterial infections (often superimposed on insect bites), and non-specific "itchy rashes" are consistently among the most common.

---

### Global skin disease morbidity and mortality: an update from the global burden of disease study 2013 [^1116MKyA]. JAMA Dermatology (2017). Medium credibility.

Key Points

Question

What is the burden of skin disease worldwide?

Findings

In this observational study, skin diseases contributed 1.79% to the global burden of disease measured in disability-adjusted life years (DALYs). Skin diseases arranged in order of decreasing global DALYs are as follows: dermatitis (atopic, contact, seborrheic), acne vulgaris, urticaria, psoriasis, viral skin diseases, fungal skin diseases, scabies, melanoma, pyoderma, cellulitis, keratinocyte carcinoma, decubitus ulcer, and alopecia areata.

Meaning

Skin diseases remain a major cause of disability worldwide. An objective measure of burden, such as the DALY, allows for comparison of diverse diseases across geography and time.

---

### Global skin disease morbidity and mortality: an update from the global burden of disease study 2013 [^115THDMT]. JAMA Dermatology (2017). Medium credibility.

Methods

The analyses were carried out by the team members of the Institute of Health Metrics and international skin experts with an interest in dermatoepidemiology. The following skin conditions were selected based on available data, standardized disease definitions, and prevalence: dermatitis (including the common varieties of eczema: atopic, seborrheic, and contact dermatitis), psoriasis, cellulitis, pyoderma, scabies, fungal skin diseases, viral skin diseases, acne vulgaris, alopecia areata, pruritus, urticaria, decubitus ulcer, malignant skin melanoma, and keratinocyte carcinoma (including basal and squamous cell carcinomas). An additional category, "other skin and subcutaneous diseases", encompasses the remainder of miscellaneous skin conditions. International Classification of Diseases, Ninth Revision (ICD-9) and ICD-10 codes were used to define each of the 15 skin disease categories (eTable 1 in the Supplement).

The initial step in the GBD estimation strategy was a thorough investigation of the world literature using PubMed and Google Scholar for data on the incidence, prevalence, remission, duration, severity, and mortality risk (only applicable for selected skin diseases) of the 15 skin conditions. Data were extracted by age, time period, and with information defining uncertainty (standard error, confidence interval, or numerator/denominator). Searches were performed in English and Spanish languages for the years 1980 through 2013. Data were extracted from more than 4000 sources including systematic reviews, surveys, population-based disease registries, hospital inpatient data, outpatient data, and cohort studies. Most incidence data for certain skin diseases were obtained from 3 medical record sources: (1) inpatient data from Europe, Latin America, and the United States, (2) outpatient data predominantly from the United States, and (3) in the case of basal cell and squamous cell carcinoma of the skin, registry data where it included keratinocyte carcinoma, for example, Northern Ireland Cancer Registry, 2010 (see eTable 2 in the Supplement for all GBD 2013 skin disease data sources).

---

### The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015 [^114DjHnr]. The Lancet: Infectious Diseases (2017). Medium credibility.

Introduction

Scabies is a skin infestation caused by the mite Sarcoptes scabiei that causes a pruritic skin eruption. Given that scabies transmission occurs with person-to-person contact, scabies is particularly prevalent in resource-poor conditions and among children, and is associated with insufficient access to health-care subsidies. Scabies can occur in any setting but over the past century has become less prevalent in temperate regions and is more common in tropical, humid regions. The predominant symptom of scabies infestation is pruritus, which can be debilitating. Disruption of the skin's protective barrier function promotes secondary bacterial infections, which can lead to additional, potentially life-threatening, complications.

Scabies has high prevalence in the tropics and large cumulative morbidity. Recognition of scabies on the global health agenda would increase awareness, education, and research into diagnosis, treatment, and prevention. In recognition, WHO recently formally designated scabies as a neglected tropical disease. Previous investigations have reported on scabies prevalence in specific, often low-resource, communities. A systematic review of 48 population-based studies found the highest prevalence of scabies in Papua New Guinea, Panama, and Fiji. However, beyond prevalence, the extent to which scabies affects these communities is unknown. In this paper, we provide estimates for the global burden of scabies skin disease using data from the Global Burden of Disease (GBD) study.

---

### Unusual localization of blood-borne loa loa microfilariae in the skin depends on microfilarial density in the blood: implications for onchocerciasis diagnosis in coendemic areas [^111XDrcK]. Clinical Infectious Diseases (2021). Medium credibility.

Onchocerciasis is a parasitic infection caused by the filarial nematode Onchocerca volvulus and transmitted by Simulium blackfly vectors. Sessile adult female worms live inside nodules or worm bundles, where they mate with the (mobile) males and periodically produce thousands of embryos or microfilariae. Microfilariae (mf) leave the nodules to populate the skin under the epidermis and the eyes and may live for a maximum of 2.5 years. Most (99%) onchocerciasis cases occur in sub-Saharan Africa. The infection is associated with skin pathology, ocular lesions that progressively lead to blindness, excess mortality, and epilepsy. The severity of these manifestations depends on the burden of infection, particularly on (past and/or present) O. volvulus microfilarial density (MFD).

In endemic countries, regional control and elimination initiatives have been implemented, based on vector control and/or mass drug administration (MDA) with ivermectin. Elimination of transmission (EOT) has been achieved in formerly endemic Latin American countries (Mexico, Guatemala, Colombia, Ecuador) under the auspices of the Onchocerciasis Elimination Program for the Americas (1993–present), with the exception of the Amazonian focus straddling Venezuela and Brazil. In Africa, the Onchocerciasis Control Programme in West Africa (OCP; 1974–2002) and the African Programme for Onchocerciasis Control (APOC; 1995–2015) led to substantial reductions in disease burden and to EOT in some foci of West and East Africa. Levels of precontrol endemicity and progress towards morbidity and EOT targets have been measured via assessment of prevalence and intensity of infection: in the OCP by detection and enumeration of skin mf by the skin snip technique (SST) and in APOC by nodule prevalence at the beginning of the program and by SST for phase 1A (monitoring prevalence decline) and phase 1B (stop-MDA) evaluations. The SST consists of taking 2 or more bloodless skin snips (typically with a Holth-type corneoscleral punch), incubating the snips in a suitable medium (eg, saline) for 24 hours, and detecting the presence (for prevalence) and number (for MFD) of emerged mf in the medium under a microscope.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^115jjVnp]. CDC (2025). High credibility.

Post-travel dermatologic conditions — Bacterial infections localized to skin and soft tissues occur most frequently when skin surface has been interrupted by abrasions, bites, or minor scratches, particularly when maintaining good hygiene is difficult; common organisms responsible are Staphylococcus aureus and Streptococcus pyogenes, and these infections are collectively called pyodermas and can present as impetigo, folliculitis, ecthyma, furuncles, cellulitis and erysipelas, or lymphangitis.

---

### Global skin disease morbidity and mortality… [^114X6d6N]. JAMA Network (2017). Excellent credibility.

viral skin diseases, 0. 15% for fungal skin diseases,
0. 07% for scabies, 0. 06% for malignant skin melanoma,
0. 05% for pyoderma, 0. 04% for cellulitis,
0. 03% for keratinocyte carcinoma, 0. 03% for decubitus ulcer, and
0. 01% for alopecia areata. All other skin and subcutaneous diseases composed 0. 12% of total DALYs. The following skin conditions were selected based on available data, standardized disease definitions, and prevalence: dermatitis, psoriasis, cellulitis, pyoderma, scabies, fungal skin diseases, viral skin diseases, acne vulgaris, alopecia areata, pruritus, urticaria, decubitus ulcer, malignant skin melanoma, and keratinocyte carcinoma. Dermatitis burden remains relatively consistent throughout all age categories, in comparison with acne vulgaris, which causes the greatest burden between the first and third decades of life.

Skin conditions with the greatest burden in younger ages also include infectious causes, such as viral skin diseases, bacterial skin diseases, and scabies. Quiz Ref IDMelanoma causes the greatest burden in Australia, followed by high-income North America, Western Europe, and Central Europe. Similarly, keratinocyte carcinoma causes the greatest burden in Australasia, the Caribbean, Central Latin America, and tropical Latin America. Dermatitis burden follows a similar geographic predominance, with a high DALY rate in central sub-Saharan Africa. Quiz Ref IDPsoriasis causes the greatest burden in Australasia, Western Europe, high-income Asia-Pacific, and southern Latin America. Burden from acne vulgaris is greatest in Western Europe, high-income North America, and southern Latin America. Central, western, and eastern sub-Saharan Africa, along with Oceania, have the highest DALY rates from cellulitis.

Global Burden of Disease 2013 demonstrates high incidence and burden of keratinocyte carcinoma in southern sub-Saharan Africa, which is hypothesized to be particularly due to mortality from keratinocyte carcinoma reflecting poor access to health care.

---

### Global skin disease morbidity and mortality: an update from the global burden of disease study 2013 [^1133wsPa]. JAMA Dermatology (2017). Medium credibility.

Importance

Disability secondary to skin conditions is substantial worldwide. The Global Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin diseases.

Objective

To measure the burden of skin diseases worldwide.

Data Sources

For nonfatal estimates, data were found by literature search using PubMed and Google Scholar in English and Spanish for years 1980 through 2013 and by accessing administrative data on hospital inpatient and outpatient episodes. Data for fatal estimates were based on vital registration and verbal autopsy data.

Study Selection

Skin disease data were extracted from more than 4000 sources including systematic reviews, surveys, population-based disease registries, hospital inpatient data, outpatient data, cohort studies, and autopsy data. Data metrics included incidence, prevalence, remission, duration, severity, deaths, and mortality risk.

Data Extraction and Synthesis

Data were extracted by age, time period, case definitions, and other study characteristics. Data points were modeled with Bayesian meta-regression to generate estimates of morbidity and mortality metrics for skin diseases. All estimates were made with 95% uncertainty intervals.

Main Outcomes and Measures

Disability-adjusted life years (DALYs), years lived with disability, and years of life lost from 15 skin conditions in 188 countries.

Results

Skin conditions contributed 1.79% to the global burden of disease measured in DALYs from 306 diseases and injuries in 2013. Individual skin diseases varied in size from 0.38% of total burden for dermatitis (atopic, contact, and seborrheic dermatitis), 0.29% for acne vulgaris, 0.19% for psoriasis, 0.19% for urticaria, 0.16% for viral skin diseases, 0.15% for fungal skin diseases, 0.07% for scabies, 0.06% for malignant skin melanoma, 0.05% for pyoderma, 0.04% for cellulitis, 0.03% for keratinocyte carcinoma, 0.03% for decubitus ulcer, and 0.01% for alopecia areata. All other skin and subcutaneous diseases composed 0.12% of total DALYs.

Conclusions and Relevance

Skin and subcutaneous diseases were the 18th leading cause of global DALYs in Global Burden of Disease 2013. Excluding mortality, skin diseases were the fourth leading cause of disability worldwide.

---

### How coronavirus disease 2019 changed dermatology practice in 1 year around the world: perspectives from 11 countries [^115gyj79]. Dermatologic Clinics (2021). Medium credibility.

Coronavirus disease 2019 (COVID-19) brought the world to its knees. As each nation grappled with launching an effective response while simultaneously minimizing repercussions on health care systems, economies, and societies, the medical and scientific landscape shifted forever. In particular, COVID-19 has challenged and transformed the field of dermatology and the way we practice. In this article, dermatologists from 11 countries share insights gained from local experience. These global perspectives will help provide a better framework for delivering quality dermatologic care and understanding how the field has evolved during this medical crisis.

---

### Allergic skin reactions in the tropics [^116WNhrk]. Clinics in Dermatology (2006). Low credibility.

Cutaneous allergic reactions are relatively common in tropical countries, with some caused by the tropical environment and others by changes in the traditional living conditions combined with poverty. HIV infection is a major contributory factor. A large number of reactions are eczematous. Atopic dermatitis is on the increase together with contact allergic reactions. Available products are often of inferior quality and contain irritants and allergens that may be forbidden elsewhere in the world. The extensive and uncontrolled use of drugs and indigenous medications together with an increase in HIV prevalence leads to drug eruptions such as the Stevens-Johnson syndrome and toxic epidermal necrolysis. Poverty plays an important role in the prevalence of insect bites and resulting papular urticaria and possibly in acropustulosis infantum. Many unexplained environmentally induced blistering diseases occur, ranging from phytophotodermatitis to fogo selvagem and from pemphigus foliaceus to chronic bullous dermatosis of childhood. This article describes the allergic conditions that occur in the tropics. Special attention is given to those cases of eczema and eruptions that are specific to tropical countries. Available treatments are also discussed.

---

### CDC yellow book 2026: health information for international travel. chapter 9 refugees, immigrants, and migrants [^112GkZSh]. CDC (2025). High credibility.

History of the present illness — symptoms after travel to low- and middle-income countries (LMICs) most commonly present as dermatologic conditions, diarrheal diseases, and systemic febrile illnesses; other common findings include animal bites and scratches, asymptomatic eosinophilia, and respiratory illnesses, and familiarity with these syndromes, their epidemiology, and their geographic occurrence will help healthcare professionals to develop a differential diagnosis and a management plan.

---

### Risk factors for asthma and allergy associated with urban migration: background and methodology of a cross-sectional study in afro-ecuadorian school children in northeastern Ecuador (esmeraldas-SCAALA study) [^114YpdTC]. BMC Pulmonary Medicine (2006). Low credibility.

The study described here is part of the Programme "Social Change, Asthma and Allergy in Latin America" (SCAALA), a research programme being conducted in Ecuador and Brazil (in the North Eastern city of Salvador), funded by The Wellcome Trust as part of the programme of Major Awards to Centres of Excellence in Latin America. The SCAALA collaboration aims to clarify the social and biological mechanisms that mediate the effect of population and lifestyle changes on the frequency of atopic diseases. This paper deals with the methodological aspects of the study being conducted in Ecuador.

The study in Ecuador aims to study changes in the prevalence and risk factors for asthma and allergy in populations that migrate from rural to urban areas and examine how such changes may relate to changes in the risk of atopic disease. The study will measure the frequency of symptoms of asthma, allergic rhinitis and atopic dermatitis in school children in urban and rural areas, and will collect detailed information on life style factors and environmental exposures that may affect the frequency of atopic diseases in the urban and rural environments. The study will investigate also changes in key immunologic factors (i.e. cytokines) and environmental exposures (i.e. exposure to aeroallergens in the household) that may be associated with altered asthma risk in the rural and urban study groups. On the other hand, the SCAALA study in Brazil aims to investigate the associations between the prevalence and incidence of allergic diseases, environmental exposures, particularly hygiene-related exposures, and immunological parameters in a cohort of children in the city of Salvador in the State of Bahia, and has been described elsewhere.

---

### Tropical dermatology: tropical diseases caused by protozoa [^116Rk8Qo]. Journal of the American Academy of Dermatology (2009). Low credibility.

Unlabelled

Protozoan infections are very common among tropical countries and have an important impact on public health. Leishmaniasis is the most widely disseminated protozoan infection in the world, while the trypanosomiases are widespread in both Africa and South America. Amebiasis, a less common protozoal infection, is a cause of significant morbidity in some regions. Toxoplasmosis and pneumocystosis (formerly thought to be caused by a protozoan) are worldwide parasitic infections with a very high incidence in immunocompromised patients but are not restricted to them. In the past, most protozoan infections were restricted to specific geographic areas and natural reservoirs. There are cases in which people from other regions may have come in contact with these pathogens. A common situation involves an accidental contamination of a traveler, tourist, soldier, or worker that has contact with a reservoir that contains the infection. Protozoan infections can be transmitted by arthropods, such as sandflies in the case of leishmaniasis or bugs in the case of trypanosomiases. Vertebrates also serve as vectors as in the case of toxoplasmosis and its transmission by domestic cats. The recognition of the clinical symptoms and the dermatologic findings of these diseases, and a knowledge of the geographic distribution of the pathogen, can be critical in making the diagnosis of a protozoan infection.

Learning Objectives

After completing this learning activity, participants should be able to recognize the significance of protozoan infections worldwide, identify the dermatologic manifestations of protozoan infections, and select the best treatment for the patient with a protozoan infection.

---

### Effects of maternal geohelminth infections on allergy in early childhood [^1132SSuR]. The Journal of Allergy and Clinical Immunology (2016). Low credibility.

Allergic diseases, such as asthma and eczema, have emerged as major health problems in many developing countries, particularly in urban Latin America. The causes of such temporal increases are likely to be explained by environmental changes.

The hygiene hypothesis has explained the increasing prevalence of allergic diseases in the context of decreasing exposures to common infectious diseases of childhoodand a decreased diversity of microbial exposures in the environment. Among potentially protective infections, there has been considerable interest in the role of geohelminth parasites (eg, Ascaris lumbricoides, Trichuris trichiura, and hookworm), which are extremely common chronic infections of childhood in developing countries, where an estimated 2 billion humans are infected. The relationship between geohelminth infections and allergy is complex. Although infections are generally associated with a reduced prevalence of allergen skin prick test (SPT) reactivity, their effects on allergic diseases are less clear. Treatment studies of geohelminths in schoolchildren have not shown effects on the prevalence of allergic diseases, or consistent increases in allergen SPT reactivity prevalence, after anthelmintic treatment. It has been suggested that in utero and early-life exposures might be important for mediating protection. Other environmental exposures that have been associated with protection against allergy, such as farming, have stronger effects when exposure occurs in utero and in early childhood.

We recruited a birth cohort in an area of Ecuador with a high maternal prevalence of geohelminth infections to test the hypothesis that in utero exposures to geohelminth parasites through having an infected mother protect against the development of eczema, wheeze, and atopy during the first 3 years of life.

---

### Use of psychotropic drugs in the dermatology patient: when to start and stop? [^112xzAvw]. Clinics in Dermatology (2018). Low credibility.

Dermatologists often find themselves treating patients with psychiatric disorders, most commonly anxiety and depression, in the context of skin disease. The psychiatric condition may either be present before the skin condition developed and exacerbate it or, in some cases, even create it (eg, delusions of parasitosis). Alternatively, the psychiatric condition may occur subsequent to the development of the dermatologic condition. The treatment of psychodermatogic disorders requires collaboration between psychiatrists and dermatologists. Dermatologists should be able to recognize primary psychiatric disorders and refer patients to psychiatrists for appropriate treatment; however, the patient may encounter delays in accessing psychiatric care, and dermatologists should be familiar with the basic use of psychotropic drugs. This review describes common psychiatric disorders encountered in a dermatology practice and their treatment with psychotropic drugs. For each commonly used drug, dose range, side effects, and how to initiate and terminate treatment are described. Although psychotherapy is an important part of the treatment of most psychiatric disorders, we have limited our focus to psychotropic drugs in this review.

---

### Antibiotics used in nonbacterial dermatologic conditions [^111A7C4s]. Dermatologic Therapy (2012). Low credibility.

The majority of nonbacterial dermatological conditions treated with antibiotics benefit from the anti-inflammatory properties of these medications, usually dapsone or tetracycline. Many other antimicrobials are used to treat noninfectious conditions. The following chapter is an overview of select noninfectious dermatological conditions for which antibiotics are used, with a focus on the most common antibiotics used for their nonantimicrobial properties.

---

### Emerging infectious diseases with cutaneous manifestations: viral and bacterial infections [^115xRNxm]. Journal of the American Academy of Dermatology (2016). Low credibility.

Given increased international travel, immigration, and climate change, bacterial and viral infections that were once unrecognized or uncommon are being seen more frequently in the Western Hemisphere. A delay in diagnosis and treatment of these diseases can lead to significant patient morbidity and mortality. However, the diagnosis and management of these infections is fraught with a lack of consistency because there is a dearth of dermatology literature on the cutaneous manifestations of these infections. We review the epidemiology, cutaneous manifestations, diagnosis, and management of these emerging bacterial and viral diseases.

---

### Pigmentary disorders in Latin America [^1169caVd]. Dermatologic Clinics (2007). Low credibility.

Pigmentary disorders with hypopigmentation/depigmentation or hyperpigmentation may have special manifestations in Latin America. Most pigmentary disorders are commonly observed in all areas of Latin America, but a few are particularly seen in tropical and subtropical regions. In most pigmentary disorder ailments described, multiple factors involved in their pathogenesis are known, but etiology remains elusive. Some pigmentary disorders have peculiar clinical expressions and, in spite of being restricted to certain geographical areas, they may be observed in other world areas because of frequent traveling of affected patients. Therapy of most of these ailments is difficult or remains unknown.

---

### Dermatological conditions in intensive care: a secondary analysis of the intensive care national audit and research centre (ICNARC) case mix programme database [^111GoLv1]. Critical Care (2008). Low credibility.

Table 2
Case mix, outcome and activity for major subgroups of dermatological admissions

Values are n (%), mean (SD) or median (IQR), as indicated. *Percentage of admissions with evidence to assess past medical history. APACHE, Acute Physiology And Chronic Health Evaluation; ICNARC, Intensive Care National Audit & Research Centre; ICU, intensive care unit; IQR, interquartile range; SD, standard deviation.

Patients with infective conditions were mostly medical admissions (52.8%) or were admitted following emergency surgery (38.3%). By comparison, the vast majority of those with dermatological malignancies were admitted following elective surgery (72.3%) and most of those with acute skin failure were non-surgical admissions (85.4%) (Table 2).

Disease severity scores, APACHE II and the ICNARC physiology score, were highest in those with infective conditions and lowest in those with cutaneous malignancies.

Length of intensive care stay was longest for those with acute skin failure (median 4.7 days for both ICU survivors and non-survivors). Length of intensive care stay and total hospital stay was shortest for those with dermatological malignancies.

The most commonly recorded non-dermatological reasons for admission among these patients were for septic shock/septicaemia (n = 573, 23.8%), acute renal failure (n = 168, 7.0%) and pneumonia (n = 95, 4.0%) (Table 3).

Table 3
Top 10 most common non-dermatological reasons for admission for patients with both dermatological and non-dermatological reasons recorded

---

### Dermatologic conditions in down syndrome [^113UhbKt]. Pediatric Dermatology (2021). Medium credibility.

Down syndrome (DS) is the most common chromosomal condition and affects many organs including the skin. Dermatologists are an integral part of the DS care team. This is a review of both common and rare dermatologic conditions in DS. We provide practical strategies for a successful dermatology interview and examination. We explore the downstream effects of trisomy of chromosome 21, in particular on the immune system, and how these insights may enhance our pathophysiologic understanding of their cutaneous conditions.

---

### Tropical dermatology: fungal tropical diseases [^111fd5MW]. Journal of the American Academy of Dermatology (2005). Low credibility.

Unlabelled

Fungal infections are common in tropical countries and can have an important impact on public health. Lobomycosis is a common fungal infection in the tropical rain forest of South America, and paracoccidioidomycosis (South American blastomycosis) is a widespread and sometimes severe illness. Penicilliosis marneffei is an opportunistic infection of AIDS patients in southeast Asia. Chromoblastomycosis and mycetomas are causes of morbidity around the world. Sporotrichosis is a worldwide subcutaneous mycosis with a high incidence in tropical countries and is an important illness in immunocompromised patients. Rhinosporidiosis was classed as a fungal infection but is now considered a protistan parasite that belongs to the class Mesomycetozoea. It is included in this review because of its historical classification. In the past, most of these mycoses were restricted to specific geographic areas and natural reservoirs. There are, however, situations in which people from other regions come in contact with the pathogen. A common situation involves an accidental contamination of a traveler or worker who has contact with a tropical mycosis. Even minor trauma to the skin surface or inhalation of the fungal conidia can infect the patient. Thus recognition of the clinical symptoms and the dermatologic findings of the diseases, as well as the geographic distribution of the pathogens, can be critical in diagnosis of the tropical mycoses. This review discusses some of the more common tropical subcutaneous and systemic mycoses, as well as their signs, symptoms, methods of diagnosis, and therapies.

Learning Objective

At the completion of this learning activity, participants should be able to recognize the clinical and histologic presentations of tropical fungal diseases with cutaneous manifestations and be familiar with the appropriate therapies.

---

### Tropical dermatology: viral tropical diseases [^115XvR99]. Journal of the American Academy of Dermatology (2003). Low credibility.

Viruses are important pathogens in tropical areas; most of them, especially the tropical hemorrhagic fevers, produce mucocutaneous manifestations. More than any other kind of pathogen, viruses have the possibility for being widespread, since they have a greater probability of mutation than do bacteria, can cross species barriers easily, and infect both human beings and animals in habitats with a great biodiversity. Tropical habitats also have been subject to major ecologic changes in the last few decades, exposing humans to direct contact with these viruses and allowing hemorrhagic fevers due to new emergent viruses such as flaviviruses, filoviruses, arenaviruses, and hantaviruses to become major threats to public health. The collapse of eradication programs in many countries, as well as population increases and ecologic modifications, have led to the spread of dengue and yellow fever to large portions of the world owing to the dissemination of vectors, especially mosquitoes, with broad ecologic ranges. Viruses previously restricted to some geographic areas, such as Rift Valley fever, Crimean-Congo hemorrhagic fever, West Nile fever, and monkeypox are now affecting new countries and populations. Other viruses such as herpes B infection often affect travelers and animal handlers in most parts of the world. Dermatologic lesions occur in all these diseases and can facilitate a rapid diagnosis, leading to control of the virus and helping prevent possible outbreaks.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^114CpGN5]. CDC (2025). High credibility.

Post-travel dermatologic conditions — Impetigo is a common, highly contagious, superficial bacterial skin infection.

---

### The impact of the COVID-19 pandemic on global health dermatology [^117BNNuQ]. Dermatologic Clinics (2021). Medium credibility.

In this article, we discuss the impact of the COVID-19 pandemic on various areas of global health dermatology, including patient care, neglected tropical diseases, education, and collaborations. Information was collected from literature review and informal interviews with more than 20 dermatologists from around the world. Many of the setbacks and hardships experienced by the global health community in the last year highlight long-standing global interdependencies and systems that perpetuate ethnic, economic, and social inequalities on local and global scales. The pandemic has brought discussions on global health colonialism and domestic health inequality to the forefront.

---

### The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries [^112SuQQR]. Journal of the American Academy of Dermatology (2020). Medium credibility.

Background

Coronavirus disease 2019 (COVID-19) has associated cutaneous manifestations.

Objective

To characterize the diversity of cutaneous manifestations of COVID-19 and facilitate understanding of the underlying pathophysiology.

Methods

Case series from an international registry from the American Academy of Dermatology and International League of Dermatological Societies.

Results

The registry collected 716 cases of new-onset dermatologic symptoms in patients with confirmed/suspected COVID-19. Of the 171 patients in the registry with laboratory-confirmed COVID-19, the most common morphologies were morbilliform (22%), pernio-like (18%), urticarial (16%), macular erythema (13%), vesicular (11%), papulosquamous (9.9%), and retiform purpura (6.4%). Pernio-like lesions were common in patients with mild disease, whereas retiform purpura presented exclusively in ill, hospitalized patients.

Limitations

We cannot estimate incidence or prevalence. Confirmation bias is possible.

Conclusions

This study highlights the array of cutaneous manifestations associated with COVID-19. Many morphologies were nonspecific, whereas others may provide insight into potential immune or inflammatory pathways in COVID-19 pathophysiology.

---

### Global coronavirus pandemic (SARS-CoV-2): past, present, and future of pediatric dermatology [^116d3uct]. Dermatologic Therapy (2020). Medium credibility.

Two months have passed since the World Health Organization (WHO) declared the pandemic of the Coronavirus Disease 19 (COVID-19), caused by the SARS-CoV-2 virus, on 11 March 2020. Medical and healthcare workers have continued to be on the frontline to defeat this disease, however, continual changes are being made to their working habits which are proving to be difficult. Although the skin is not the main target of the SARS-CoV-2 infection, it is strongly involved both directly and indirectly, in many aspects of dermatological disease management, and particularly in pediatric dermatology. In this manuscript, our goal was to provide a "up-to-date" account on this topic, through analysis of current literature and sharing our experiences during this pandemic.

---

### Post-travel dermatologic conditions | Yellow book | CDC… [^111KtR5U]. CDC (2025). Medium credibility.

Impetigo Impetigo is a common, highly contagious, superficial bacterial skin infection. S. aureus and S. pyogenes are the most common pathogens. Streptococcal impetigo classically presents in children with golden or "honey-colored" crusts formed from dried serum. Staphylococcal impetigo often appears in body folds, especially the axillae, and might present as fragile pustules. Gnathostomiasis is a nematode infection that occurs mainly in Southeast Asia, along the Pacific coast of Ecuador and Peru, in parts of Mexico, and Sub-Saharan Africa. People acquire gnathostomiasis by eating raw or undercooked, infected freshwater fish, amphibians, or reptiles. Infected individuals experience transient, migratory, subcutaneous nodules often described as both itchy and painful. Onchocerciasis can occur in expatriates living in endemic areas in Sub-Saharan Africa.

Onchocercal dermatitis manifests as a generalized pruritic, finely papular dermatitis, a rare finding in travelers that occurs years after exposure. Swimmer's itch and hookworm folliculitis are extremely itchy eruptions composed of papules on skin surfaces exposed to freshwater and fecally-contaminated soils, respectively. Anthrax Cutaneous anthrax starts as a large, edematous swelling. Within a few days, the skin surface develops a shallow ulcer that progresses into a necrotic black eschar. In all stages, anthrax lesions are surprisingly painless. Most cases of travel-associated anthrax are cutaneous and are acquired via exposure to live ruminants or from handling unprocessed products made from animal hides or wool.

The most virulent SSTI associated with marine and estuarine exposures are due to Vibrio vulnificus and related non-cholera Vibrio spp. For freshwater exposures, Aeromonas hydrophila is the most dangerous pathogen. Various skin and soft tissue manifestations can occur in association with either infection, including abscess formation, cellulitis, ecthyma gangrenosum, and necrotizing fasciitis.

---

### Climate change and dermatologic diseases in the global south: a rising challenge [^113EpDmG]. Dermatologic Clinics (2026). Medium credibility.

Climate change is reshaping the epidemiology of dermatologic diseases in the Global South through rising temperatures, UV radiation, extreme weather events, and shifting ecosystems. These environmental stressors exacerbate thermal injuries, infectious and inflammatory dermatoses, and neglected tropical diseases such as cutaneous leishmaniasis, mycetoma, and scabies. Vulnerable populations-including displaced communities, persons with albinism, and outdoor workers-face disproportionate risk. This article highlights the dermatologic impacts of climate change, emphasizing the need for integrated surveillance, accessible care, and climate-resilient health systems. Addressing these challenges requires urgent, interdisciplinary action to protect skin health and equity in an increasingly warming and unstable world.

---

### CDC yellow book 2026: health information for international travel. chapter 4 travel-associated infections and diseases [^114TpYcj]. CDC (2025). High credibility.

Leishmaniasis — epidemiology and cutaneous leishmaniasis distribution — In 2021, leishmaniasis was reported to be endemic in 99 countries, and an estimated 600,000 to 1,000,000 new cases of CL and 50,000 to 90,000 new cases of VL occur annually. In the Eastern Hemisphere, CL is found in Africa, particularly the tropical region and North Africa; Asia, particularly Central and Southwest Asia; southern Europe, including southern France, Greece, Italy, Portugal, Spain, and the Mediterranean islands; and some countries of the Middle East, and leishmaniasis from these areas is often referred to as "Old World" leishmaniasis. In the Western Hemisphere, CL is found in parts of Mexico, all countries of Central America, and most of South America except Chile and Uruguay; Endemic transmission in the United States has been identified in Texas, especially among people living in areas bordering northeastern Mexico, and possibly in Arizona and Oklahoma, while Endemic transmission of CL is not found in Canada; leishmaniasis from these areas is often referred to as "New World" leishmaniasis. GeoSentinel Surveillance from 1997–2017 indicated that among patients with laboratory confirmed CL at specialized travel or tropical medicine clinics on 6 continents, common source countries for travel-associated CL included the Amazon Basin (Brazil, Bolivia, Colombia, Ecuador, and Peru), Costa Rica, El Salvador, and Israel; among immigrants, Afghanistan and Syria were common sources, and cases in US service personnel reflected military activities in Afghanistan and Iraq.

---

### National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study [^113TUrBq]. BMJ (2020). Excellent credibility.

Fig 3
Crude lifetime (physician or dermatologist diagnosed) prevalence of psoriasis in children according to world regions. Regions with observed data: Australasia, central Europe, east Asia, eastern Europe, eastern sub-Saharan Africa, high income Asia Pacific, high income North America, North Africa and the Middle East, south Asia, South East Asia, tropical Latin America, western Europe. Regions with extrapolated data: central Asia, high income southern Latin America, Caribbean, Andean Latin America, central Latin America, Oceania, central sub-Saharan Africa, southern sub-Saharan Africa, western sub-Saharan Africa

Fig 4
Crude lifetime (physician or dermatologist diagnosed) prevalence of psoriasis in adults according to world regions. Regions with observed data: Australasia, central Europe, east Asia, eastern Europe, eastern sub-Saharan Africa, high income Asia Pacific, high income North America, North Africa and the Middle East, south Asia, South East Asia, tropical Latin America, western Europe. Regions with extrapolated data: central Asia, high income southern Latin America, Caribbean, Andean Latin America, central Latin America, Oceania, central sub-Saharan Africa, southern sub-Saharan Africa, western sub-Saharan Africa

---

### Dermatologic care and skin health of migrant populations in the US: a scoping review [^112MS1Tb]. JAMA Dermatology (2025). High credibility.

Importance

Despite literature on migrant skin health globally, there remains a critical gap in understanding the dermatologic care and skin health of migrants in the US, where immigrants represent 13.9% of the population.

Objective

To understand the spectrum of dermatologic conditions reported among US migrant populations, identify considerations for dermatologic care delivery, and synthesize the current literature on skin health.

Evidence Review

PubMed, Embase, and ClasePeriodica were searched for articles published from January 2000 to December 2022 using search terms related to dermatologic conditions and migrants. Original research articles, review articles, case reports, and case series that reported on dermatologic conditions affecting migrant populations within the US and US territories were included.

Findings

Of 87 articles included, cross-sectional studies accounted for 37 (42.5%), followed by case reports and case series (36 [41.4%]), qualitative studies (3 [3.4%]), and a mixed-methods study (1 [1.1%]). Articles discussed a range of dermatologic conditions: infections (45 [51.7%]), inflammatory conditions (33 [37.9%]), traumatic wounds (16 [18.4%]), neoplasms (10 [11.5%]), pigmentary disorders (10 [11.5%]), signs of torture/violence (4 [4.6%]), cosmetic (3 [3.4%]), hair/nail disorders (1 [1.1%]), and genodermatoses (1 [1.1%]). Of 65 articles (74.6%) reporting migrants' country of origin, Mexico was most frequently reported (28 [43.0%]), followed by Guatemala (14 [21.5%]), Vietnam (8 [12.3%]), and 38 other countries. Four themes were developed: (1) exposures before and during migration were risk factors for dermatologic conditions that presented at destination; (2) occupational and environmental exposures were risk factors for dermatologic conditions that developed at destination; (3) structural factors limited migrants' access to quality health care; and (4) educational interventions targeting different learner groups were opportunities to improve skin health of migrants.

Conclusions and Relevance

This scoping review found that exposures before, during, and after migration and health care access are associated with the skin health of US migrant populations. Research opportunities include focusing on a broad spectrum of dermatologic diseases, countries of birth, occupations, and vulnerable populations, such as women and children, as well as implementing and evaluating policy that addresses structural barriers migrants face in accessing quality health care.

---

### Risk factors for asthma and allergy associated with urban migration: background and methodology of a cross-sectional study in afro-ecuadorian school children in northeastern Ecuador (esmeraldas-SCAALA study) [^113UgfLr]. BMC Pulmonary Medicine (2006). Low credibility.

Discussion

Atopic asthma and other allergic diseases are becoming increasingly important public health problems in Latin American cities and there is little published information on the causes of this disease epidemic. The SCAALA (Social Change, Asthma and Allergy in Latin America) research initiative includes two epidemiological studies being conducted in urbanizing populations (Esmeraldas Province, Ecuador and the city of Salvador in Brazil, respectively) that are investigating the environmental causes of allergy in urban Latin America and the biological and social mechanisms that underlie these epidemiological trends. While the SCAALA-Salvador aims to investigate the associations between the prevalence of asthma and other allergic diseases (rhinitis, atopic eczema) and potential risk factors that includes living conditions and early life and current exposures to infections, the SCAALA-Esmeraldas study aims to study frequency of atopy and allergic diseases and exposure to potential risk factor in rural populations and in migrants from rural to urban areas and examine how these may explain the risk of atopic diseases in migrants from rural to urban areas. Both studies will investigate how the association between environment factors, allergic diseases and markers of atopy (i.e. skin-prick test and total and specific serum IgE levels) may be mediated by interleukins from antigen-stimulated leukocytes.

The Esmeraldas-SCAALA study in Ecuador includes cross-sectional and nested case-control studies conducted in rural and urban contexts. The studies are investigating the impact of urban migration on asthma risk and the environmental exposures that are associated with an increased risk of asthma in populations that migrate from rural to urban areas. The study will focus on a single ethnic cultural group, Afro-Ecuadorians, that traditionally has lived in the remote rural North Eastern region of Esmeraldas Province, but that has migrated in significant numbers over the past 30 years to cities such as the provincial capital, Esmeraldas. The study of a single and easily identifiable group that presumably shares the same genetic 'stock' and that has migrated locally (within the same Province) should allow important environmental risk factors to be identified more easily and should not suffer from the biases that limit the interpretation of studies that have investigated populations that have migrated between countries. Specifically, the study, by investigating a migrant population, will distinguish between the effects of early life exposures (inducing immune programming) and current exposures in determining allergy risk.

---

### Management of pain associated with selected conditions in dermatology [^1148afCq]. American Journal of Clinical Dermatology (2016). Low credibility.

Dermatologists face a wide range of pain control challenges in daily practice, from the transient pain of dermatologic surgery to the persistent pain that plagues some chronic dermatologic conditions. Although the pathophysiology of pain is well described and the profound impact of dermatological pain on patients' quality of life is well appreciated, there is an identified need for clear therapeutic plans for providing symptomatic pain relief of common painful dermatoses. In this paper, we will review and clearly outline approaches to pain management of a number of common painful dermatoses such as herpes zoster and post-herpetic neuralgia, ulcers, oral dermatoses, dysesthesias, and many others.

---

### Defining the need for dermatologic surgery global health in an afro-caribbean country [^117ReFBe]. Dermatologic Surgery (2021). Medium credibility.

The objectives of this study were to quantify the relative types of cutaneous tumors in patients treated by the DMM and Ministry of Health partnership and also to assess current skin cancer knowledge, attitudes, and practices (KAPs) concerning skin cancer in Grenada. Results will help identify key skin cancer prevention and education needs in Grenada and to guide other countries with populations comprised of dark skin tones, including those in Caribbean and in the African continent. This is an underrepresented demographic in skin cancer research.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^111zffxG]. CDC (2025). High credibility.

History of the present illness and host susceptibility — post-travel evaluation — highlights that after travel to LMICs, the most common clinical syndromes are dermatologic conditions, diarrheal diseases, and systemic febrile illnesses, with other common presentations including animal bites and scratches, asymptomatic eosinophilia, and respiratory illnesses. Familiarity with these syndromes, their epidemiology, and their geographic occurrence helps healthcare professionals develop a differential diagnosis and management plan. When evaluating an ill returned traveler, assess host susceptibility, including a review of childhood immunizations and the traveler's vaccination history, including COVID-19 vaccination.

---

### Liver derivative complex (Nexavir) [^1115QjpD]. FDA (2020). Medium credibility.

INDICATIONS AND USAGE:

A wide range of dermatological clinical conditions benefit from NEXAVIR®therapy. The common denominator in these varied conditions is the presence of inflammation and edema. Favourable responses to the administration of NEXAVIR®in patients with acne vulgaris5,6,7,8, herpes zoster, "poison ivy" dermatitis, pityriasis rosea, seborrheic dermatitis, urticaria and eczema9,10,11, severe sunburn12and rosacea13have been reported.

---

### Allergic symptoms, atopy, and geohelminth infections in a rural area of Ecuador [^112Jrzap]. American Journal of Respiratory and Critical Care Medicine (2003). Low credibility.

Geohelminth infections may affect the expression of allergic disease. To investigate the relationship between geohelminth infections, atopy, and symptoms of allergic disease, we studied 4433 schoolchildren from 71 schools in a rural tropical area in Ecuador. Information was collected on allergic symptoms, allergen skin test reactivity, and presence of geohelminth infections. Allergic symptoms were of low prevalence (2.1% had recent wheeze), but prevalence of skin test reactivity was relatively high (18.2%). The presence of geohelminth infections was protective against allergen skin test reactivity (odds ratio 0.62, 95% confidence interval 0.50–0.76, p < 0.001) and symptoms of exercise-induced wheeze (odds ratio 0.59, 95% confidence interval 0.40–0.87, p = 0.008) but not against other wheeze symptoms or symptoms of allergic rhinitis or atopic eczema. Infection intensity with Ascaris lumbricoides or Trichuris trichiura was associated with a reduction in the prevalence of allergen skin test reactivity but not with allergic symptoms. There was no evidence of interactions between geohelminth infection and allergen skin test reactivity on the risks of allergic symptoms. The results suggest that geohelminth infections do not explain the low prevalence of allergic symptoms in the study population.

---

### Hygiene, atopy and wheeze-eczema-rhinitis symptoms in schoolchildren from urban and rural Ecuador [^112AgR2k]. Thorax (2014). Low credibility.

Background

Rural residence is protective against atopy and wheeze-rhinitis-eczema symptoms in developed countries, an effect attributed to farming and poor hygiene exposures. There are few data from developing countries addressing this question. We compared atopy and wheeze-rhinitis-eczema symptoms between urban and rural Ecuador, and explored the effects of farming and poor hygiene exposures.

Methods

We performed cross sectional studies of schoolchildren living in rural and urban Ecuador. Data on symptoms and farming/hygiene exposures were collected by parental questionnaire, atopy by allergen skin prick test reactivity and geohelminth infections by stool examinations.

Results

Among 2526 urban and 4295 rural schoolchildren, prevalence was: atopy (10.0% vs 12.5%, p = 0.06), wheeze (9.4% vs 10.1%, p = 0.05), rhinitis (8.1% vs 6.4%, p = 0.02) and eczema (5.9% vs 4.7%, p = 0.06). A small proportion of symptoms were attributable to atopy (range 3.9–10.7%) with greater attributable fractions for respiratory symptoms observed in urban schoolchildren. Respiratory symptoms were associated with poor hygiene/farming exposures: wheeze with lack of access to potable water; and rhinitis with household pets, no bathroom facilities and contact with large farm animals. Birth order was inversely associated with respiratory symptoms. Area of residence and atopy had few effects on these associations.

Conclusions

Urban schoolchildren living in Ecuador have a similar prevalence of atopy, eczema and wheeze but a higher prevalence of rhinitis compared with rural children. Some farming and poor hygiene exposures were associated with an increase in the prevalence of wheeze or rhinitis while birth order was inversely associated with these symptoms.

---

### Dermatology COVID-19 registries: updates and future directions [^112yREe7]. Dermatologic Clinics (2021). Medium credibility.

During the COVID-19 pandemic, rapid, real-world evidence is essential for the development of knowledge and subsequent public health response. In dermatology, provider-facing and patient-facing registries focused on COVID-19 have been important sources of research and new information aimed at guiding optimal patient care. The 7 dermatology registries included in this update now include more than 8000 case reports sourced from physicians and patients from countries all over the world.

---

### CDC yellow book 2026: health information for international travel. chapter 9 refugees, immigrants, and migrants [^115bNjoP]. CDC (2025). High credibility.

Skin ulcers — these form when destructive processes breach the epidermis and enter the dermis; the most frequent causes of acute (duration < 1 month) cutaneous ulcers are Staphylococcus and Streptococcus, producing well-demarcated, shallow ulcers with sharp "punched out" borders known as bacterial or common ecthyma; while some conditions (e.g., chancre of primary syphilis) are ulcerated at onset, most begin as an elevated papule or vesicle and evolve into an erosion or ulcer as the surface breaks down.

---

### Dermatologic manifestations of extreme heat, wildfires, and flooding [^111tuinv]. Dermatologic Clinics (2026). Medium credibility.

Recent climate science trends have identified that extreme weather events, including heat waves, wildfires, and flooding, are becoming more frequent and intense worldwide. These climatic events have negative impacts on dermatologic health, particularly on multiple inflammatory and infectious skin diseases. It is increasingly important for dermatologists to be knowledgeable about these impacts in order to appropriately diagnose, treat, and prevent these illnesses for their patients.

---

### Skin manifestations of arthropod-borne infection in Latin America [^112s7DLC]. Current Opinion in Infectious Diseases (2014). Low credibility.

Purpose Of Review

Arthropods are a significant cause of human skin lesions and infections, especially in Latin America. This review summarizes recent articles on the cutaneous manifestations of arthropod-borne diseases, with an emphasis on those diseases causing direct skin damage but also considering those systemic diseases with cutaneous manifestations.

Recent Findings

Studies have shown a variety and increase of cutaneous manifestations caused by arthropod-borne infections, including petechiae, purpura, ulcers, nodules, atrophic, miliary and hyperpigmented lesions. Although unspecific, when considering other features they become a useful tool in the diagnostic approach. Unusual cutaneous presentation of these diseases has been found to be associated with development of immunity, virulent strain, drug resistance and immunosuppressive states. Also, because of globalization, climate change and large-scale migration, these manifestations have spread to new areas.

Summary

Cutaneous manifestations of arthropod-borne infections are varied and nonspecific. Their atypical presentations are mainly related to immune impairment and strain virulence. When considering a patient with skin lesions, other clinical and laboratory features must be taken into account in order to make an accurate diagnostic approach.

---

### Global skin disease morbidity and mortality: an update from the global burden of disease study 2013 [^114dfEeE]. JAMA Dermatology (2017). Medium credibility.

Introduction

Global disability and mortality due to skin disease has been investigated by the Global Burden of Disease (GBD) 2013 Study. The GBD is a collaboration of more than 1000 experts worldwide, aiming to create a systematic, quantified, and internally consistent source of health information. Based at the Institute for Health Metrics and Evaluation and funded by the Bill and Melinda Gates Foundation, GBD 2013 provides disability and mortality metrics for diseases, injuries, and risk factors stratified by age, sex, location, and time. Disease burden was estimated using the metric of disability-adjusted life year (DALY), which is the sum of years of life lost to a disease (YLLs) plus years lived with disability (YLDs). One DALY is equivalent to 1 year of healthy life lost. (pp6-7) This measurement unit allows for cross-comparison of diverse disease states. The goal of GBD is to produce the highest-quality epidemiologic data by ensuring transparent analytic strategies that include uncertainty distributions, promote internal consistency, and allow iterative revisions over time. Each GBD iteration incorporates new studies and improved methodology, creating a "living" database to inform clinical, research-oriented, and policy-making decisions. This rolling design of the data set allows for the addition of new data sources and improvements to the methods of estimation. Global Burden of Disease 2013 made estimates for 306 diseases and injuries in 188 countries. As GBD researchers and collaborators, we present results for 15 dermatologic conditions.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^115JUUde]. CDC (2025). High credibility.

Post-travel dermatologic conditions — Rocky Mountain spotted fever (RMSF) is a tick-borne rickettsial disease that is more severe than other spotted fevers, occurs in North America (US and Mexico) and parts of Central and South America, and because of its potential severity and lethality and the need for early treatment, consider RMSF when evaluating patients with fever and rash; most patients with RMSF develop a rash 3–5 days after illness onset that starts as a blanching maculopapular eruption, progresses as cutaneous blood vessels become inflamed and leaky with non-blanching petechiae especially on the ankles and wrists, usually spreads to palms and soles then becomes generalized, and patients are usually very ill with high fever and severe headaches.

---

### Cutaneous diseases in latinos [^113HhiyK]. Dermatologic Clinics (2003). Low credibility.

The knowledge of many specific skin diseases that predominantly affect Latinos has been increasing; however, the understanding of common skin disease in Latinos is superficial. There are few prospective studies done in the Latino population and none that differentiate between diverse Latino backgrounds. In view of the expanding Latino population in this country, such research is timely.

---

### Epidemiology of chronic dermatologic conditions in skin of color [^114QNSUa]. Journal of Drugs in Dermatology (2023). Medium credibility.

Across the board, common dermatologic conditions disproportionately affect patients of color. While the causes of these disparities have been tied to the environment, societal structure, access to care, health literacy, and biological factors, there is limited understanding of the extent and impact of dermatologic healthcare inequity. This study provides a resource on the epidemiology of common dermatologic diseases across racial lines and points out current lapses in scientific understanding of the disparate impact of certain conditions.&nbsp; This study will review epidemiological data on atopic dermatitis (AD), adult acne, pseudofolliculitis, dermatophytosis, psoriasis, vitiligo, melasma, hyperpigmentation, keloids, hidradenitis suppurativa (HS), basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma. J Drugs Dermatol. 2023;22(11):e21-e23&nbsp; &nbsp; doi:10.36849/JDD.7131e.

---

### How can we better integrate the prevention, treatment, control and elimination of neglected tropical diseases with other health interventions? A systematic review [^113HT2ut]. BMJ Global Health (2021). High credibility.

Traditionally, there has been a disease-specific approach to tackling NTDs, through community-based mass campaigns and clinical management. For example, soil transmitted helminths (STH) and schistosomiasis are managed through MDA as preventive chemotherapy. Due to geographical overlap, limited resources and changing environments, global health actors have been advocating for integrated disease management. To increase awareness, upgrade treatment coverage and improve patient outcomes, the WHO has suggested that stakeholders should improve intersectoral coordination (eg, with WASH and tropical diseases research and training); integration across diseases and continued improvements to the medicine and resources supply chain.

The new 2021–2030 WHO roadmap emphasises integrated NTD management to sustain the efforts made over previous years under the theme 'Ending the neglect to attain the Sustainable Development Goals' (SDGs). The WHO, policy-makers and academics have also suggested that endemic countries should integrate NTD management strategies using existing resources and into existing health interventions, since many of these diseases are coendemic. The WHO recommended the integration of NTDs into well-established public health programmes such as HIV/AIDS, malaria, maternal and child health and WASH programmes, or within NTDs (for example those that manifest as skin conditions — skin NTDs). Meanwhile, the UN has been advocating for Universal Health Coverage (UHC), in which communities are able to 'use the promotive, preventive, curative, rehabilitative, and palliative health services they need, of sufficient quality to be effective, while also ensuring that the use of these services does not expose the user to financial hardships'. The SDGs are robust in recognising the relationship between poverty, politics and health. Thus, they acknowledge the importance of controlling NTDs while conceptualising the main mission of UHC, which is 'leaving no one behind'.SDG 3 aims to achieve health equity through ensuring a healthy life and promoting well-being for all people. Tackling these neglected diseases is vital in health and development because UHC cannot be achieved if marginalised communities are still suffering. It is also a major step to reducing global poverty. Bangert et al noted how the integrated management of NTDs can help achieve several of the SDGs and vice versa. They indicated that integrated strategies to combat NTDs can boost global partnerships (SDG17), increase economic growth (SDG8) and generally reduce inequality (SDG10).

---

### The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015 [^111xpZ19]. The Lancet: Infectious Diseases (2017). Medium credibility.

Western sub-Saharan Africa

Benin, Burkina Faso, Cameroon, Cape Verde, Chad, Côte d'Ivoire, The Gambia, Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, São Tomé and Príncipe, Senegal, Sierra Leone, and Togo

Southern sub-Saharan Africa

Botswana, Lesotho, Namibia, South Africa, Swaziland, and Zimbabwe

Eastern sub-Saharan Africa

Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mozambique, Rwanda, Somalia, South Sudan, Tanzania, Uganda, and Zambia

Central sub-Saharan Africa

Angola, Central African Republic, Congo (Brazzaville), Democratic Republic of the Congo, Equatorial Guinea, and Gabon

Tropical Latin America

Brazil and Paraguay

Andean Latin America

Bolivia, Ecuador, and Peru

Central Latin America

Colombia, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, and Venezuela

Caribbean

Antigua and Barbuda, The Bahamas, Barbados, Belize, Bermuda, Cuba, Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Puerto Rico, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago, and Virgin Islands

Western Europe

Andorra, Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and UK

Southern Latin America

Argentina, Chile, and Uruguay

North America

Canada, Greenland, and USA

Asia Pacific

Brunei, Japan, Singapore, and South Korea

Australasia

Australia and New Zealand

---

### The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries [^115Arpss]. The Journal of Investigative Dermatology (2015). Low credibility.

Questionnaires

The first part of the questionnaire recorded socio-demographic variables including self-reported socio-economic status. Ethnicity was self-assigned by each participant referring to their own country of birth. Stress was assessed with the item "Have you had any stressful life events during the last 6 months?" with a possible answer of "yes" or "no".

Symptoms of depression and anxiety, the main outcome variables, were assessed with the HADS, a well-validated instrument showing good psychometric properties, to assess severity and presence of anxiety disorders and depression in somatic, psychiatric, and primary care patients, as well as in the general population. HADS includes seven items assessing anxiety and seven for depression, each with four possible answers. For each dimension of anxiety and depression a score from 0 to 7 is considered a normal case, from 8 to 10 a borderline case, and from 11 to 21 a case in need of further examination or treatment. This instrument was used in the validated translations relevant to the study countries.

To assess suicidal ideation, we included the item "Have you ever thought of committing suicide?" with possible answers "yes" or "no": we were not able to identify a validated item on suicidal ideation. An additional question was given to the patient group: "Have you ever thought of committing suicide because of your skin?" with an item on frequency when the answer was yes.

---

### CDC yellow book 2026: health information for international travel. chapter 10 post-travel evaluation [^113YEGaK]. CDC (2025). High credibility.

Post-travel fever evaluation — clinical reassessment and skin findings can guide diagnosis. If the initial examination is unrevealing, the text advises to repeat the exam at least daily if the diagnosis is not clear because new findings might appear that will help in the diagnostic process, and notes that although most febrile illnesses are infectious, other conditions including pulmonary emboli and drug hypersensitivity reactions also can be associated with fever. Fever as part of a clinical syndrome deserves further scrutiny because it could indicate a disease of public health concern; yet undifferentiated presentations are common in malaria, typhoid fever, or dengue, and this distinction provides only a rough guide because malaria may present with focal symptoms, so misdiagnosing a patient with gastroenteritis who actually has malaria could negatively impact outcome. Dermatologic presentations are frequent in returned travelers; skin rashes can evolve rapidly and lesion types and locations can aid diagnosis of systemic infections (e.g., arboviral infections, measles, spotted fever group rickettsioses, typhoid fever, acute schistosomiasis, or acute HIV infection), and petechial or purpuric lesions may indicate meningococcal disease.

---

### The geospatial relationship of pterygium and senile cataract with ambient solar ultraviolet in tropical Ecuador [^117ShCV7]. Photochemical & Photobiological Sciences (2018). Low credibility.

In Ecuador, the incidence of ocular pterygium in 2010 was 34.39 per 100,000 person-years.

---

### Prevalence of rare diseases: bibliographic data [^111B1e6S]. Orphanet Report Series (2024). Medium credibility.

Worldwide, the prevalence of wrinkly skin syndrome is estimated at 0.0003797 per 100,000 population.

---

### Consumer perspectives on and utilization of medical cannabis to treat dermatologic conditions [^1166S9Zr]. Journal of Drugs in Dermatology (2022). Medium credibility.

Background

Access to medical cannabis products (MCPs) has rapidly increased though literature on consumer behaviors and attitudes with regards to dermatologic use is limited.

Objective

We sought to address the gap of knowledge regarding consumer utilization and perspectives surrounding MCPs for dermatologic indications.

Methods

A survey was emailed via SurveyMonkey&rsquo; s platform to adult users of their rewards panel asking about usage patterns and beliefs regarding MCP use to treat dermatologic conditions.

Results

504 of 700 survey invitations sent out were completed (72% response rate). 17.6% of respondents used an over-the-counter (OTC) cannabis product without dermatologist recommendation to treat a skin condition [most common indications: acne (28.4%) and psoriasis (26.1%)]. Of those who had seen a dermatologist, 15.3% used an OTC product [most common indications: psoriasis (32%) and rosacea (30%)] and 7.8% used an MCP which required a Department of Health-approved card per their dermatologist&rsquo; s recommendations [most common indications: acne (68%) and psoriasis (28%)]. 11.8% of respondents were not comfortable seeing a dermatologist who recommended MCPs.

Limitations

Limitations include small sample size as well as selection bias.

Conclusion

Consumers are interested in and are using MCPs for dermatologic indications, most commonly for inflammatory skin disorders. Targeted education for dermatologists is recommended. J Drugs Dermatol. 2022;21(1):31–36. doi:10.36849/JDD.6540.

---

### Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017 [^114Hz5t8]. Lancet (2018). Excellent credibility.

The following constitutes key background information on skin abscess:

- **Definition**: A skin abscess is a localized collection of pus within the dermis and deeper skin tissues, typically caused by bacterial infection.
- **Pathophysiology**: The pathophysiology involves the invasion of bacteria into the skin, often through a break in the skin barrier. The body's immune response to this invasion leads to inflammation and the formation of pus, which is a collection of dead WBCs, bacteria, and tissue debris.
- **Epidemiology**: The incidence of skin abscess worldwide is estimated at 1861.45 per 100,000 person-years.
- **Risk factors**: Risk factors for skin abscesses include poor hygiene, trauma to the skin, and underlying medical conditions that compromise the immune system, such as diabetes or HIV infection. Other local factors, such as the presence of foreign materials or conditions like hidradenitis suppurativa and pilonidal cyst, can also contribute to the development of skin abscesses.
- **Disease course**: Clinically, skin abscesses typically present as a painful, red, swollen area on the skin. There may also be a visible accumulation of pus. In some cases, systemic signs of infection such as fever may be present.
- **Prognosis and risk of recurrence**: The prognosis for skin abscesses is generally good with appropriate treatment, which typically involves incision and drainage, and in some cases, antibiotic therapy.

---

### Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases [^111UdRKC]. The British Journal of Dermatology (2020). Medium credibility.

Background

The cutaneous manifestations of COVID-19 disease are poorly characterized.

Objectives

To describe the cutaneous manifestations of COVID-19 disease and to relate them to other clinical findings.

Methods

We carried out a nationwide case collection survey of images and clinical data. Using a consensus we described five clinical patterns. We later described the association of these patterns with patient demographics, the timing in relation to symptoms of the disease, the severity and the prognosis.

Results

The lesions may be classified as acral areas of erythema with vesicles or pustules (pseudo-chilblain) (19%), other vesicular eruptions (9%), urticarial lesions (19%), maculopapular eruptions (47%) and livedo or necrosis (6%). Vesicular eruptions appear early in the course of the disease (15% before other symptoms). The pseudo-chilblain pattern frequently appears late in the evolution of the COVID-19 disease (59% after other symptoms), while the rest tend to appear with other symptoms of COVID-19. The severity of COVID-19 shows a gradient from less severe disease in acral lesions to more severe in the latter groups. The results are similar for confirmed and suspected cases, in terms of both clinical and epidemiological findings. Alternative diagnoses are discussed but seem unlikely for the most specific patterns (pseudo-chilblain and vesicular).

Conclusions

We provide a description of the cutaneous manifestations associated with COVID-19 infection. These may help clinicians approach patients with the disease and recognize cases presenting with few symptoms. What is already known about this topic? Previous descriptions of cutaneous manifestations of COVID-19 were case reports and mostly lacked illustrations. What does this study add? We describe a large, representative sample of patients with unexplained skin manifestations and a diagnosis of COVID-19, using a consensus method to define morphological patterns associated with COVID-19. We describe five clinical patterns associated with different patient demographics, timing and prognosis, and provide illustrations of these patterns to allow for easy recognition.

---

### Travelers' tropical skin diseases: challenges and interventions [^1166kN7c]. Dermatologic Therapy (2019). Medium credibility.

Tropical regions receive a significant part of the traveling population. It is very important that health professionals are familiar with the main tropical skin diseases and able to advice patients appropriately. This article reviews the main tropical diseases of travelers, with an emphasis on diagnosis, management, and prevention. Among others, cutaneous larva migrans, myiasis, tungiasis, Chagas disease, Dengue fever, African trypanosomiasis, filariasis, and leishmaniasis are discussed. Increasing awareness among travelers and health care professionals can help reduce morbidity and mortality. Continued research on new drugs and vaccines is needed to reduce the risks of tropical diseases.

---

### Prevalence of rare diseases: bibliographic data [^113yDs2q]. Orphanet Report Series (2024). Medium credibility.

In Europe, the prevalence of dermatitis herpetiformis is estimated at 27 per 100,000 population.

---

### Psoriasis – epidemiology and clinical spectrum [^116aZdez]. Clinical and Experimental Dermatology (2001). Low credibility.

Despite psoriasis being a common skin disease, there are still a number of unanswered questions. One of these is the prevalence of the disease, as there is a lack of specific data, with the majority of studies reporting estimates only. Population based studies are rare and longitudinal observations on changing prevalence rates are lacking. This contrasts with other T-cell mediated autoimmune diseases where the number of those affected is rising. Epidemiological studies revealed that a distinct group of diseases is quite frequently associated with psoriasis, e.g. arthritis, colitis, diabetes and hypertension. In contrast, atopic dermatitis and allergies are less frequently seen compared to normal rates of occurrence. As the psoriatic immune response pattern relates to activated Th-1 cells, psoriasis and atopic dermatitis appear to be mutually exclusive due to the Th-1/Th-2 dichotomy.

---

### Lobomycosis in soldiers, Colombia [^1164P4XF]. Emerging Infectious Diseases (2019). Medium credibility.

Discussion

In Colombia, lobomycosis occurs in Amoruas and Motilones aboriginal communities in the Amazon and Orinoco regions and in black persons in the Pacific Coast regions of Cauca and Choco. The presence of this disease in soldiers from Colombia who are stationed in jungle or forest regions is a unique situation in which all factors (tropical climate, temperature, humidity, rainfall) related to an optimal habitat for the fungus are present.

Lobomycosis is found in Central and South America (Mexico, Costa Rica, Panama, Venezuela, Colombia, Guyana, Bolivia, Suriname, Ecuador, and Peru). Cases that develop outside the Amazon region need an ecology similar to that of jungle areas. Rare cases have been reported in North America and Europe in persons who have traveled to countries in South America. However, 2 cases have occurred in persons outside Central and South America who had no history of travel: 1 in a young man who reported swimming in South Africa and 1 in a farmer (woman) who lived in a river basin in Greece.

---

### Superficial cutaneous fungal infections in tropical countries [^111MusL7]. Dermatologic Therapy (2009). Low credibility.

Superficial fungal infections represent an important cause of morbidity for people worldwide, particularly in the tropics. Fungal infections affect the skin, hair, or the nails, and tend to thrive in the heat and humidity of tropical countries. Because of environmental and cultural factors unique to the tropics, the causative organisms and presentation of these infections may differ from those in industrialized countries. Treatment options include topical and systemic therapy. However, social and socioeconomic factors in developing tropical countries may necessitate different treatment approaches to achieve success.

---

### Primary care of adult women: common dermatologic conditions [^1147QtSx]. Obstetrics and Gynecology Clinics of North America (2016). Low credibility.

Dermatologic disease often presents in the primary care setting. Therefore, it is important for the primary care provider to be familiar with the presentation, diagnosis, and treatment of common skin conditions. This article provides an overview of acne, rosacea, melasma, vitiligo, alopecia, nonmelanoma, and melanoma skin cancer, dermatitis, and lichen sclerosus.

---

### The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries [^113jvry2]. The Journal of Investigative Dermatology (2015). Low credibility.

Results

In total, 5,067 individuals agreed to take part––3,651 patients and 1,416 controls. The participation rate was 79.9%. Of the initial 3,651 patients, 16 were excluded, 9 because they were too young and 6 because of missing data, leaving 3,635. Of the initial 1,416 controls, 57 were excluded because they had a skin disease, leaving 1,359 (see flow chart).

The subject characteristics are given in Table 1: there were more females in both the patient and control populations. The mean patient age was 47 years versus 41 years for the controls, P < 0.001. Overall 92% participants originated from the country where the study took place (data not shown). The socio-economic level distribution was similar in the two groups. Overall 35.6% of the patients reported stress compared with 30.6% of the controls, P < 0.001. Overall patients had more physical co-morbidities compared with the controls, 28.8% versus 16.0%, P < 0.001.

---

### Skin disorders in diabetes mellitus: an epidemiology and physiopathology review [^112jfALM]. Diabetology & Metabolic Syndrome (2016). Low credibility.

Although prior studies showed increased risk of infection in DM patients, little evidence is found in the literature to support increased risk for cutaneous infectious diseases. In general, skin disorders are highly associated to poorly controlled DM patients. A good glycemic control may reduce the incidence and severity of cutaneous disorders with or without known pathogenesis. Nonspecific skin disorders that occur in DM patients can increase the likelihood of exposure to infectious organisms and contact with allergens, resulting in chronic and recurrent infections and eczemas, respectively. However, further studies are required, since all available data are still not concordant. Additionally, Farshician et al. did not find a significant relationship between the diabetic disease control and the prevalence of cutaneous infection. Moreover, most cross-sectional studies assessed in this review do not allow causal explanations. Thus, further investigation is required to better understand the risk of cutaneous infection.

Xerosis was reported in several studies and rates showed high heterogeneity. Goyal et al. showed a high prevalence of xerosis (44%) in a single center observational study mainly related to weather and dry climatic conditions. According to Pavlovic, skin dryness is one of the earliest and most common manifestations of type 1 DM. Clinical observations are supported by a reduced hydration state of the stratum corneum and decreased sebaceous gland activity in DM patients, without any impairment of the stratum corneum barrier function. Even in the absence of clinically apparent xerosis, patients with diabetes have an impaired desquamation process. Furthermore, occurrence of xerosis may be affected not only by the type of diabetes but also to regional changes in climate and humidity.

---

### Prevalence of rare diseases: bibliographic data [^113EGtph]. Orphanet Report Series (2024). Medium credibility.

Worldwide, the prevalence of stiff skin syndrome is estimated at 0.00077 per 100,000 population.

---

### COVID-19-specific skin changes related to SARS-CoV-2: visualizing a monumental public health challenge [^111ixVXA]. Clinics in Dermatology (2021). Medium credibility.

The novel coronavirus SARS-CoV-2 has caused coronavirus disease-2019, known as COVID-19, now a pandemic stressing millions of individuals worldwide. COVID-19 is a systemic respiratory infection that may have dermatologic signs and systemic sequelae, a devastating public health challenge with parallels to the two great influenza pandemics of the last century. Skin lesions linked with COVID-19 have been grouped into six categories, with three distinct indicative patterns: vesicular (varicella-like), vasculopathic, and chilblains-like (including "COVID toes" and "COVID fingers") plus the following three less suggestive patterns: dermatitic, maculopapular, and urticarial morphologies. Vasculopathic changes are the most concerning, in some patients, reflecting a devastating blood clotting dysfunction. We discuss the ways to detect, prevent, and treat COVID-19, keeping in mind the context of possible cutaneous markers of COVID-19 to enhance detection.

---

### Dermatological concerns in the latino population [^112eMib2]. Journal of Drugs in Dermatology (2019). Medium credibility.

The Latino, or Hispanics in the United States, are the drivers behind demographic growth. They are heterogeneous in many dimensions related to health risks and dermatological conditions. Understanding the heterogeneity and clinical manifestation of skin concerns in such population is essential for health care providers.